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ABSTRACT OF THE DISSERTATION
Functional Significance of Glycoprotein Clearance by the Asialoglycoprotein Receptor
and the Mannose/GalNAc-4-SO4 Receptor
By
Lindsay Michelle Steirer Taylor
Doctor of Philosophy in Molecular Cell Biology
Washington University in St. Louis, 2009
Professor Jacques U. Baenziger, Chairperson

Glycosylation plays an important role in many biological functions. Two highly
abundant, carbohydrate-specific, endocytic receptors reside in parenchymal and
endothelial cells of the liver. Our lab has shown that the asialoglycoprotein receptor
(ASGR) is capable of clearing glycoproteins bearing terminal Siaα2,6GalNAc as well as
ones bearing terminal Gal/ GalNAc and that the Mannose/GalNAc-4-SO4 receptor (MR)
is capable of clearing glycoproteins bearing terminal GalNAc-4-SO4. I am taking a
genetic approach identifying endogenous ligands for the ASGR and the MR in vivo and
establishing the biologic significance of clearing these glycoproteins from the blood. A
number of glycosylated hormones such as luteinizing hormone (LH), thyroid stimulating
hormone, and the prolactin like proteins bear structures that would be recognized by
either the ASGR or the MR and clearance would potentially help regulate their
concentrations following release into the blood.
I have obtained ASGR-/-, MR-/-, and ASGR-/-MR-/- mice. I am using mass
spectrometric methods to identify glycoproteins that are elevated in the blood of these
vii

mice. Glycoproteins bearing Siaα2,6Gal are elevated in ASGR-/- mice suggesting that
glycoproteins with Siaα2,6Gal rather than terminal Gal or GalNAc are cleared by the
ASGR. Many are acute phase proteins and we propose that the ASGR helps regulate
their relative concentrations in vivo and enhances their increase during the acute phase
response. LH bears terminal GalNAc-4-SO4 and the half life of LH is increased in MR-/mice indicating that the MR does account for LH clearance in vivo. ASGR-/- mice also
have elevated LH, but the half life is not increased indicating an alternative mechanism of
elevating LH in ASGR-/-, likely through a protein bearing Siaα2,6Gal/GalNAc.
Ablation of both the MR and ASGR results in mice that are fertile, but unable to induce
parturition. This suggests clearance of proteins bearing Siaα2,6Gal/GalNAc and
GalNAc-4-SO4 is critical for appropriate plasma protein levels changes associated with
parturition. Clearance by the ASGR and MR may contribute to regulating the
concentrations of a range of glycoproteins including acute phase proteins and hormones.
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Chapter 1
Introduction

1

Glycosylation is essential for a variety of biological processes including protein
folding [1], proteolytic stability [2], and clearance rate [3]. Most proteins are
glycosylated [4, 5]. Here, we focus on the significance of glycosylation in clearance of
glycoproteins circulating in the blood. Clearance of glycoproteins is based on the
specific recognition of the protein's oligosaccharide structure by carbohydrate specific
receptors. We propose two receptors, the asialoglycoprotein receptor (ASGR) and the
mannose/GalNAc-4-SO4 receptor (MR) regulate plasma protein levels of proteins bearing
specific carbohydrates.
The ASGR and MR are known to bind and clear glycoproteins bearing unique Nlinked oligosaccharides terminating with Siaα2,6GalNAcβ1,4GlcNAcβ1,2Manα
(Siaα2,6GalNAc) [6],and SO4-4GalNAcβ1,4GlcNAcβ1,2Manα (GalNAc-4-SO4) (Figure
1), respectively [7-10]. Only a few proteins bearing these unique structures have been
identified, but the proteins that have been identified play a major role in reproduction.
The synthesis of the oligosaccharide structures is regulated hormonally and
developmentally [11, 12] . However, the significance of clearing circulating
glycoproteins bearing these structures is unknown in terms of regulating circulating
levels and glycoprotein turnover. There is evidence the ASGR and MR are involved
during two significant events, the acute phase response and sexual reproduction. In this
thesis, we set out to understand the importance of two highly abundant receptors found in
the liver, the ASGR and MR, in regulating the circulating concentrations of proteins
bearing Siaα2,6Gal and GalNAc-4-SO4 in unperturbed animals and during the acute
phase response and sexual reproduction.
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The Asialoglycoprotein Receptor and Mannose/GalNAc-4-SO4 Receptor. There are
two highly abundant receptors found in the liver, the ASGR and the MR, known to bind
and clear glycoproteins bearing two unique oligosaccharides, Siaα2,6GalNAc and
GalNAc-4-SO4, respectively. Both receptors were identified based on their ability to
bind other structures, terminal galacose (Gal) and mannose (Man), but our lab has
established they are capable of binding these two additional structures. Both receptors
have been studied extensively to understand their carbohydrate specificity and function;
however the precise function of both receptors remains unknown.
Asialoglycoprotein Receptor
The ASGR was first identified in the early 1970s by Ashwell and Morell [13].
Early studies determined that while native ceruloplasmin, a copper binding protein
modified with sialic acid (Sia), circulates in plasma for days, removal of the Sia and
exposure of the penultimate structure, Gal, results in ceruloplasmin that circulates in
plasma for minutes. Therefore, the terminal structure on ceruloplasmin determines the
circulatory half life. While observing clearance of ceruloplasmin, it was found to
accumulate in the parenchymal cells of the liver [14] and binding is to the plasma
membrane of the liver [15]. For maximal binding to occur, the pH needs to be 7.8-8.5
and there is an absolute requirement of calcium [15]. No more than two Gal residues on
a single protein are necessary for rapid removal from circulation [13], and the affinity of
different ligands for the receptor depends on the position [16] and number of
carbohydrate chains [17].
Clearance studies in which exogenous ligands are radiolabeled and injected into
an animal are useful for determining circulatory half-life. When the ASGR was
3

originally identified, clearance studies were conducted using radiolabeled native
ceruloplasmin, which bears Sia, and asialoceruloplasmin, which bears terminal Gal. It
was found that within 15 minutes of injection, 90% of native ceruloplasmin remained in
the blood whereas less than 10% of asialoceruloplasmin remained in the blood. The
majority of the radioactivity was found in the liver [14]. This suggests the terminal
structure present on oligosaccharides terminal the circulatory half-life of proteins in the
blood.
The ASGR has been isolated from a number of hepatic organelles, including the
golgi, microsomes, and lysosomes [18]. This in combination with the topological
distribution of the receptor, in which the receptor is found on the luminal membrane
surface of the golgi complex [19] suggest it undergoes a recycling mechanism. This was
later confirmed and studied extensively by Gueze et al [20]. The ligand and receptor are
internalized together by endocytosis [21] in coated pits and vesicles [22]. The ASGR is
an abundant receptor with as many as 500,000 surface receptors per cell [23] but there
may be twice as many receptors present including internalized receptors[24].
It was presumed for nearly 30 years that the ASGR binds asialolglycoproteins;
however, in this time, proteins bearing terminal Gal were never identified. To identify
endogenous ligands and attempt to elucidate the function of the ASGR, two knockout
mouse models were produced, one for each subunit. In the mouse, the ASGR is
composed of two subunits, mouse hepatic lectins 1 and 2 (MHL1/2), and both are
required for expression of a functional receptor [25-28] Studies have been conducted on
each of the subunits to elucidate their roles [29, 30]. In 1994, a genetic ablation model
for mice lacking one of the two receptor subunits, the subunit that does not bind, MHL2
4

was generated [31]. Surprisingly, it was found that there was no accumulation of
asialoglycoproteins in the blood. Several years later, the MHL1 subunit was knocked out
in mice, and again, there was no accumulation of asialoglycoproteins in the blood [32].
Interestingly, in the absence of the ASGR, no proteins were found to accumulate in the
blood. Ablation of either receptor should result in a nonfunctional receptor and any
proteins that utilize the receptor should accumulate in the plasma. If the true ligands for
the ASGR are proteins bearing terminal Gal/GalNAc, proteins bearing these structures
should have accumulated in the plasma. The absence of elevated proteins, specifically
bearing terminal Gal/GalNAc begged the question of what is the true function of the
ASGR.
To date, no endogenous ligands had been identified for the ASGR. While
studying a protein specific GalNAc-transferase, we identified a group of proteins,
prolactin-like proteins (PLPs) bearing a unique oligosaccharide terminating with
Siaα2,6GalNAc [12]. Surprisingly, neoglycoconjugates bearing this structure were
cleared by the ASGR, and proteins bearing Siaα2,6GalNAc were identified as the first
potential endogenous ligands for the ASGR. We found the optimal pH and Ca2+
dependence are similar, suggesting it coordinates with the same calcium as Gal/GalNAc.
Additionally we found the ASGR is partially inhibited by 20mM Sia, suggesting Sia may
also bind HL1 of the ASGR, just as Gal/GalNAc do [33]. Using bacterially expressed
CRDs of HL1 we studied binding of sialylated glycoproteins [6].

The binding of three

neoglycoconjugates bearing Siaα2,6GalNAc, Siaα2,6Gal, and Siaα2,3Gal was compared
to the binding of Gal. We found binding activity for Siaα2,6Gal/GalNAc, but
Siaα2,3Gal. Biantennerary core-fucosylated N-glycan (BiF)10-[125I]BSA, bearing
5

terminal Gal, SiaGGnM-[125I]BSA, bearing Siaα2,6GalNAc, and BiF1226-[125I]BSA
bearing Siaα2,6Gal, bound with a Kds of 0.45 μM, 1.26 μM and 3.6 μM respectively.
There was an 8-16 fold reduction in the binding of Siaα2,6Gal compared to terminal Gal,
but binding of Siaα2,6Gal is detectable and highly specific.
Utilizing the MHL2 knockout (ASGR-/-) model, we examined clearance rates of
Gal and Siaα2,6Gal/GalNAc. We found clearance was greatly reduced in ASGR-/- mice
for both Gal and Siaα2,6GalNAc. The majority of plasma proteins bear Sia linked to the
C3 or C6 hydroxyl of Gal. There was no specific clearance mechanism known for either
Siaα2,3Gal or Siaα2,6Gal but the clearance of proteins bearing each structure has been
examined in the plasma. Clearance of Siaα2,3Gal and Siaα2,6Gal is difficult to detect
because the half-life is long and a large number of proteins bearing these structures exist
in circulation that neoglycoconjugates would compete with, but it is clear Siaα2,6Gal has
a shorter half-life that Siaα2,3Gal, suggesting there is a specific clearance mechanism for
Siaα2,6Gal, but not Siaα2,3Gal [34].
The ASGR has been implicated in an inflammatory stimulus known as the acute
phase response (APR). During the APR, protein concentrations of acute phase proteins
(APPs) change dramatically. The cause of the elevation is known to be synthesis, but the
ASGR may also be involved. The ASGR shuts down within hours following exposure to
cytokines. Within the first few hours, the decrease in binding is due to the inactivation of
the receptor by phosphorylation, and hours later, there is decreased synthesis of the
receptor[35]. Sialic acid terminating proteins that have been implicated in the APR begin
to increase within 3-6 hours. In animals with a functioning ASGR, any immediate
6

increase in APPs may be due to decreased removal from the blood by inactive ASGR
rather than increased synthesis by the liver.
The ASGR has also been implicated in pregnancy. It was found that the binding
activity of the ASGR begins to elevate at day 10 of pregnancy and elevates at much as
three fold immediately prior to parturition. Additionally, there is enhanced endocytosis
of the ASGR[36]. There may be a drastic change in proteins produced by the mother and
fetus during pregnancy that the ASGR is responsible for clearing.
Most recently, Grewal et al [37] showed elevations of vonWillebrand factor
(vWF) and reduced bleeding time in mice lacking MHL1. Additionally, they found
platelets are eliminated after they are desialylated by a sialidase produced by
Streptococcus pneumoniae. These two observations suggest a function for the ASGR.
Interestingly, they did not find the same phenotype in mice ablated for MHL2. We and
others have shown MHL1 and MHL2 are both required for binding and clearance of
asialolglycoproteins.
Clearance by carbohydrate specific receptors may be an essential mechanism for
plasma glycoprotein turnover. Rates of turnover are hard to determine for proteins
bearing Siaα2,6Gal is because the half life is extremely long. Additionally, the methods
currently used inject exogenous ligands, which would compete with endogenous ligands
for binding and clearance. In this thesis, I use an alternative method in which two
dimensional difference gel electrophoresis and lectin blotting is used to identify proteins
bearing Siaα2,6Gal as endogenous ligands for the ASGR.

7

Mannose/GalNAc-4-SO4 Receptor
In addition to the ASGR, there is a second highly abundant receptor found in the
liver. Following the identification of the ASGR, the Mannose Receptor (Man-R) was
identified in the late 1970s in alveolar macrophages as a protein that binds to Man,
GlcNAc, and fucose [38, 39]. Many years later, this receptor was implicated in clearance
of an alternative unique structure GalNAc-4-SO4. Similar to the ASGR, the receptor
requires a pH above 5.0 for binding, but binding of GalNAc-4-SO4 is not dependent on a
divalent cation [40].
Clearance of a specific protein by the MR, luteinizing hormone (LH) bearing
GalNAc-4-SO4, was compared to that of desulfated LH, bearing terminal GalNAc , and
recombinant sialylated LH to determine the role of its glycosylation. The circulatory
half-life was determined in order to establish the significance of the GalNAc-4-SO4 on
bovine LH (bLH). We found the circulatory half-life of native LH is cleared 4-5 times
faster than recombinant LH bearing sialylated oligosaccharides, 7.3%/min compared to
1.7%/min. The desulfated bLH is rapidly cleared by the liver, presumably by the ASGR.
The clearance of native bLH is approximately 7.3%/min while desulfated LH clears at
35%/min. We concluded the GalNAc-4-SO4 protects the bLH from this rapid
clearance[40].
Our lab subsequently purified the GalNAc-4-SO4 receptor from the liver [41].
The receptor, termed the S4GGnM-receptor (S4GGnM-R), was similar to the MR in
amino terminal sequence, peptide maps, peptide sequences, and molecular weight [4245]. The main difference was the lung form of the receptor (Man-R) bound Man and the
liver form of the receptor (S4GGnM-R) bound GalNAc-4-SO4. Remarkably, Man-R
8

cDNA expressed in CHO cells binds both Man and GalNAc-4-SO4, confirming the ManR and the S4GGnM-R are encoded by the same gene. Further analysis of these two
receptors determined they were actually the same receptor, and the receptor was renamed
the Mannose/GalNAc-4-SO4 Receptor (MR) [46].
The MR has different ligand specificities suggesting it is used for multiple
functions. We postulated there must be structural features of the MR that differentiate
the MR in the liver and the MR in the lung. We found that the receptor exists in a
monomeric form while binding mannose and a dimeric form while binding GalNAc-4SO4. Posttranslational modification in macrophages and hepatic endothelial cells likely
account for the different specificities of the two forms of the receptor [47].
The MR is comprised of a cysteine-rich (cys-rich) domain, fibronectin type II
repeats, carbohydrate recognition domains (CRDs), transmembrane domain, and a
cytoplasmic tail [44, 45]. Binding of glycoproteins bearing Man is to CRDs 4-8 and
multiple Man termini are optimal for effective ligands [48, 49]. Previously, the CRDs
were the only region of the MR to bind proteins. Using deletion mutations, we
determined an alternative region is responsible for binding to GalNAc-4-SO4, the cys-rich
region [50]. Crystal structure analysis determined the Cys-rich region forms a Ricin-type
β-trefoil structure and binds GalNAc-4-SO4 [51].
The MR is found in hepatic endothelial cells and Kupffer cells, is highly abundant
in the liver with up to 600,000 receptors per cell, and rapidly internalizes glycoproteins
for degradation in the lysosome [40]. Extensive research has been conducted on binding
of LH to the MR. The binding affinity for LH is 1.7x10-7 M and circulating LH levels are
in the range of 0.1x10-9-1.0x10-9 M [47]. Although circulating LH levels fall below the
9

Kd for binding to the MR, the abundance of the MR on the cell surface provide sufficient
capacity to bind LH.
We determined the MR clears LH based on the GalNAc-4-SO4 oligosaccharide,
but this does not prove the MR mediates clearance of proteins bearing GalNAc-4-SO4 in
vivo. In order to accomplish this, we needed genetic evidence. Our lab and Michel
Nussenzweig's lab have produced mice with genetically ablated MR [52, 53].

In our

model, we found clearance of bLH, which bears GalNAc-4-SO4, is slowed in mice
heterozygous for the MR [53]. Nussenzweig's model showed decreased clearance of a
number of neoglycoconjugates including GalNAc-4-SO4-BSA and Man-BSA. However,
clearance of porcine LH clearance is not prolonged [52]. Enormous amounts, 50 μg of
porcine LH, potentially saturated the MR and porcine LH may bear oligosaccharides
terminating with Siaα2,6Gal/GalNAc, which would be cleared by the ASGR, accounting
for this discrepancy.
Previous experiments have determined the MR binds and clears GalNAc-4-SO4
found on several proteins including glycoprotein hormones. However, little information
about clearance of endogenous ligands is known and the function of the MR needs to be
elucidated. Investigation of significance of the MR in regulating plasma protein
concentrations in vivo is key to understanding its function. In this thesis, we provide
evidence that the MR regulates endogenous LH and elevated LH leads to multiple
physiologic changes.

10

Proteins recognized by the ASGR and MR are modified by a protein-specific
GalNAc-transferase and an α2,6sialyltransferase or GalNAc-4-sulfotransferase.
There are three structures that are focused on in this thesis: Siaα2,6Gal/GalNAc
and GalNAc-4-SO4. Little is known about the clearance of Siaα2,6Gal, but it is a
common N-linked structures found on many plasma proteins. The Sia may be linked to
Gal in one of two linkages, either α2,6 or α2,3. To synthesize this structure, there are
two separate enzymes; the first enzyme, β1,4galactosyltransferase adds Gal to GlcNAc
[54] and the second enzyme α2,6sialyltransferase adds Sia to Gal [55]. The second less
common structure found on a few plasma proteins terminates with Siaα2,6GalNAc.
Siaα2,6GalNAc binds and is cleared by the ASGR [6]. This structure also utilizes the
α2,6sialyltransferase, following modification by another unique enzymes β1,4GalNActransferase (βGT). The third structure, GalNAc-4-SO4 is also a unique structure, and is
recognized by the MR. The structure GalNAc-4-SO4 utilizes β1,4GalNAc-transferase
[56, 57], and those structures are further modified by GalNAc-4-sulfotransferase.
Addition of GalNAc and sulfate is done on a protein specific bases. These transferases
are found in multiple locations, but most importantly, they are found in the anterior
pituitary and the placenta, where the glycoprotein hormones bearing these structures are
synthesized. These enzymes are conserved from fish to man, suggesting oligosaccharides
modified by these enzymes are significant[58].
Regulation of glycoproteins bearing GalNAc-4-SO4 and Siaα2,6GalNAc are during
sexual reproduction. Essential reproductive hormones are regulated by an endocrine
system known as the hypothalamic-pituitary-gonadal axis (Figure 2). Luteinizing
11

hormone, synthesized and released from the anterior pituitary stimulates its receptor on
the gonads, inducing production of steroid hormones including testosterone,
progesterone, and estrogen. The steroid hormones in turn feedback to the hypothalamus
and pituitary to control synthesis and release of LH from the pituitary.
The LH receptor (LHR) is a G-protein coupled receptor with seven
transmembrane domains. Steroiogenic actions of LH are mainly through cAMPmediated events in the gonads [59]. In order for maximal stimulation of the LHR on the
gonads, the LHR must be episodically stimulated. Episodic stimulation by pulsatile
release of LH from the pituitary and possibly clearance by the MR may be necessary to
maintain LHR levels and major increases in LH can cause downregulation of the LHR
and desensitization to the hormonal signal [59, 60].
Rapid clearance of LH may be essential for maximal stimulation of the LHR. Our
lab has determined LH bears the unique oligosaccharide structure GalNAc-4-SO4 and is
rapidly cleared by the MR. The oligosaccharides on a number of species’ LH have
GalNAc and sulfate, and we determined GalNAc-4-SO4 is present on glycoprotein
hormones of all vertebrates [58]. Bovine LH and ovine LH both bear predominantly
sulfated oligosaccharides, but human LH bears both sulfated and sialylated
oligosaccharides [8, 9, 58]. This suggests LH may be cleared by both the MR and the
ASGR.
LH is comprised of two subunits, a common alpha subunit utilized by other
proteins including follicle-stimulating hormone (FSH) and thyroid stimulating hormone
(TSH) and a unique beta subunit. The alpha subunit is identical for each of the proteins
[61, 62], but the oligosaccharide modifications found on the beta subunits differ. The
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alpha subunit of the glycoprotein hormones has two N-linked glycosylation sites and the
beta subunit has one or two N-linked glycosylation sites. LH specifically may bear none,
one, or two sulfated structures. Although it is unknown what percentage of the N-linked
glycosylation sites bear Siaα2,6GalNAc, recently we found evidence that LH may bear
Siaα2,6GalNAc in addition to GalNAc-4-SO4.
Our lab has produced a genetic model knocking out the G4ST1 (G4ST1-/-) that
alters the clearance of LH by the MR. We found that in G4ST1-/- mice, terminal
GalNAc is modified with Sia. Clearance of LH is slightly longer; however, LH is still
specifically cleared. Circulating LH levels are elevated causing elevated estrogen and
testosterone. Female have enlarged uteri, presumably caused by the elevated estrogen.
Additionally, females are very fertile producing 50% more pups than Wt females. These
results suggest rapid clearance of LH is significant for regulation of the HPG axis [63].
During pregnancy, proteins bearing Siaα2,6GalNAc have been identified in the
placenta. There is expression of βGT in the placenta, but G4STs are not found in the
placenta, leading us to identify proteins bearing Siaα2,6GalNAc. Prolactin-like proteins
(PLPs) were identified in the placenta bearing the unique structure Siaα2,6GalNAc [12].
The significance of the structure and function of the oligosaccharide on the PLPs is not
clear; however, clearance of the PLPs by the ASGR likely plays a key role in pregnancy.
The role of the MR needs to be elucidated. Circulatory half-life may be important
in maintaining appropriate LH levels and regulating the HPG axis. Further studies with
MR-/- mice and ASGR-/- mice are crucial for understanding the importance of regulating
LH levels. In this thesis, we use MR-/- and ASGR-/- mice to elucidate the role of these
receptors in regulating the HPG axis. Additionally, steroid hormones are key during
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pregnancy, but how these receptors are involved in pregnancy remains unknown. We
provide evidence that receptor message levels are regulated throughout pregnancy,
suggesting they play a role in pregnancy.
Regulation of plasma protein concentrations by the Asialolglycoprotein Receptor
and Mannose/GalNAc-4-SO4 Receptor is essential. This thesis focuses on
determining the biological significance of protein level regulation of proteins bearing
Siaα2,6Gal/GalNAc and GalNAc-4-SO4 by the ASGR and the MR. Both receptors are
highly abundant in the liver, but their precise function still needs to be elucidated. The
ASGR binds proteins bearing Siaα2,6Gal/GalNAc and we can observe clearance of
neoglycoconjugates bearing Siaα2,6GalNAc. Mice lacking the ASGR have decreased
clearance of Siaα2,6GalNAc. Clearance of Siaα2,6Gal is slow and this structure is found
on a large number of proteins, causing competition and therefore cannot be observed in
the liver by traditional clearance studies.
For many years, it has been presumed the ASGR clears circulating glycoproteins
bearing Gal; however, proteins bearing terminal Gal have not been identified. We have
evidence that the ASGR binds to glycoproteins bearing Siaα2,6Gal and we now propose
the main glycoproteins cleared by the ASGR bear Siaα2,6Gal. Mice with ablated MHL2
have previously been studied to identify proteins elevated in the plasma, but proteins
bearing terminal Gal/GalNAc or Siaα2,6Gal/GalNAc were not identified. New methods
in which proteins are fluorescently labeled and separated by two dimensional difference
gel electrophoresis, then visualized together are used in this thesis to identify proteins that
are elevated in the plasma of ASGR-/- mice. In Chapter 2, I identify proteins that are
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elevated in ASGR-/- plasma bearing Siaα2,6Gal. The proteins are highly abundant
proteins, including haptoglobin and SAP, and many are involved in the APR.
In the plasma of the ASGR knockouts, proteins are significantly elevated and the
majority of those proteins are APPs. Furthermore, ASGR has been previously implicated
in the elevation of those specific proteins during APR. In Chapter 3, I demonstrate the
ASGR does play a role in elevating proteins during the APR. We identified multiple
proteins, including two of the proteins previously identified in unperturbed ASGR-/mice. In ASGR-/- mice, the fold change is not as dramatic compared to Wt but
nonetheless, the overall protein levels do change. We propose that in addition to
increased synthesis of APPs by the liver, decreased clearance by the ASGR assists in
elevating APPs.
Glycoprotein hormones bear two unique structures, Siaα2,6GalNAc cleared by
the ASGR and GalNAc-4-SO4 cleared by the MR. In the absence of one or both of these
receptors, we would expect LH to be elevated because the half-life should be increased
and downstream targets of LH, such as testosterone, should be elevated. In Chapter 4, I
determine the endogenous half-life of LH in ASGR-/-, MR-/- and MR-/-ASGR-/-. The
half life of LH is longer in MR-/- and MR-/-ASGR-/- mice leading to elevated LH levels.
ASGR-/- mice also have elevated LH, but there clearance rate is not decreased,
suggesting there is an alternative mechanism elevating LH in these animals. Mice with
elevated LH have additional physiologic changes associated with elevated LH, including
elevated testosterone and enlarged seminal vesicles.
In Chapter 5, I determine the significance of the ASGR and the MR in the estrus
cycle, during pregnancy, and at the time of parturition. As previously determined,
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ablation of the ASGR and MR results in elevated steroid hormone levels. Steroid
hormones, and specifically progesterone play a major role in pregnancy and parturition.
We show that MR-/-ASGR-/- mice are fertile, but are unable to induce parturition. The
message levels of the MR and ASGR drastically change throughout pregnancy,
suggesting they play a major role in pregnancy and parturition.
Chapter 6 summarizes the work of my thesis and suggests potential roles of the
ASGR and MR in physiological events including the APR and pregnancy. Additionally,
I discuss future important studies including determining the regulation of the ASGR and
MR during physiological events such as the APR and pregnancy.
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Abbreviations
ASGR, asialoglycoprotein receptor; MR, mannose/GalNAc-4-SO4 receptor; Sia, sialic
acid; Gal, galactose; GalNAc, N-acetylgalactosamine; GlcNAc, N-acetylglucosamine;
Man, mannose; MHL, mouse hepatic lectin; PLP, prolactin-like proteins; CRD,
carbohydrate recognition domain; APR, acute phase response; APP, acute phase protein;
vWF, vonWillebrand factor; BiF, biantennerary core-fucosylated N-glycan; LH,
luteinizing hormone; LHR, LH receptor; CHO, Chinese hamster ovary cells; BSA,
bovine serum albumin; HPG, hypothalamic-pituitary-gonadal.
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Figures
Figure 1. Three structures are focused on in this thesis, found on the glycoproteins of
interest. Panel A: Siaα2,6Gal; Panel B: Siaα2,6GalNAc: Panel C: GalNAc-4-SO4
Figure 2. Hypothalamic-pituitary-gonadal axis. LH binds to LHR on leydig cells in
the testes causing production of testosterone. Testosterone induces spermatogenesis in
the sertoli cells of the testes, signals to other target tissues, such as seminal vesicles, and
signals to the hypothalamus and pituitary to regulate synthesis and release of LH. LH is
released into the blood from the pituitary and once in the blood, it will stimulate the LHR
on leydig cells or be cleared from circulation by the MR or AR.
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Chapter 2
The Asialoglycoprotein Receptor Regulates Levels of Plasma Glycoproteins
Terminating with Sialic Acid α2,6Galactose
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Chapter 3
The ASGR regulates plasma protein concentrations during the acute phase response
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Introduction
Following an inflammatory stimulus, changes in physiologic functions occur
within hours. The acute phase response (APR) is an inflammatory stimulus, such as an
infection or trauma[64], and is induced by the rapid release of cytokines, such as TNF-α,
interleukin-1, and interleukin-6[65]. This process results in concentration changes of a
number of proteins, including C-reactive protein, serum amyloid A (SAA), haptoglobin,
and hemopexin [64, 66-69]. Increased synthesis of these glycoproteins plays a major
role in elevating their circulating concentrations [70]. Additionally, multiple plasma
proteins that are involved in the APR terminate with Siaα2,6Gal/GalNAc [71]and
changes in structure and ASGR binding activity suggest the ASGR may decrease
clearance in order to increase plasma protein concentrations.
During the APR, the expression level of the ASGR decreases in HepG2 cells. The
ASGR shuts down within hours following exposure to cytokines, specifically IL-2.
Following 4 hours of incubation with IL-2, 50% of the binding activity remains, and
following 24 hours of incubation, only 20% of the binding activity remains. Within the
first few hours, the decrease in binding is due to the inactivation of the receptor by
phosphorylation[35]. There is decreased synthesis of the receptor also, but this does not
occur until hours later. Sialic acid terminating proteins that have been implicated in the
APR begin to increase within 3-6 hours, long before the synthesis of receptor is
decreased. In animals with a functioning ASGR, any immediate increase in APPs may be
due to decreased removal from the blood by inactive ASGR rather than decreased
synthesis of the ASGR in addition to increased synthesis of APPs by the liver. If this is
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the case, ASGR-/- animals may have increased concentrations of essential APPs much
earlier than normal animals.
Dramatic increases in plasma proteins terminating with sialic acid (Sia), the
structure that has been implicated in our studies, have also been implicated in the APR.
Almost all of the APPs are glycoproteins, and recent studies have suggested that there is a
change in expression of sialyltransferases, including ST6GalI, which is the
sialyltransferase that adds terminal sialic acid (Sia) to Gal to form Siaα2,6Gal, and Sia
terminating glycoproteins, including haptoglobin β-chain and hemopexin during the
APR[72]. Essentially all Gal residues become modified with Sia[73]. If the APPs are
modified to terminate with Sia, then the ASGR may have a critical role in their clearance
from the blood during the APR.
Many of the proteins elevated in ASGR-/- mice are APPs, including haptoglobin,
hemopexin and SAP. The ASGR-/- mice have elevated APPs, but a major APP, Creactive protein, is not elevated, indicating these unperturbed animals are not undergoing
an APR [71]. Here, we show that when ASGR-/- mice undergo an APR, the APPs
further increase. Specific isoforms, mainly acidic isoforms are highly elevated compared
to Wt. However, the total protein levels of two proteins, haptoglobin and hemopexin do
not have as dramatic a fold change in ASGR-/- compared to Wt between times 0 and 24
hrs. This suggests clearance by the ASGR in addition to increased synthesis of APPs by
the liver is required to elevate APPs bearing Siaα2,6Gal.
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Methods
Cecal ligation and puncture (CLP) – Male mice were anesthetized with halothane and
one treatment group underwent laparotomy and CLP as previously described [74] and the
other treatment group, sham, underwent laparotomy but no CLP. Animals were
sacrificed at 24 hrs and plasma was collected.
Plasma Preparation—Blood was collected from the inferior vena cava of Wt and ASGR/- mice at 0 hrs and 24 hrs after an APR using a 1-ml syringe and a 23-gauge needle
treated with EDTA to prevent coagulation. The blood was diluted 1:1 with 20 mM PO4,
pH 7.4, 150 mM NaCl (PBS) containing 20 mM EDTA. Leukocytes and erythrocytes
were separated from the plasma by sedimentation for 10 min at 0.5 x g. The protein
concentration of the plasma was determined using a modified Lowry method (PlusOne
2D-Quant Kit, GE Healthcare).
Cyanine Dye Labeling—Plasma samples from ASGR-/- sham, ASGR-/- CLP and Wt
CLP mice containing 25 µg of protein were separately diluted 1:10 in 30 mM Tris-HCl,
pH 8.5, 7 M urea, 2 M thiourea, and 4% CHAPS (w/v). The diluted samples from ASGR/- sham, ASGR-/- CLP and Wt CLP mice were labeled with 200 pmol of 3-(4carboxymethyl)phenylmethyl-3'-ethyloxacarbocyanine halide N-hydroxysuccinimidyl
ester (Cy2),
1-(5-carboxypentyl)-10-propylindocarbocyanine halide N-hydroxysuccinimidyl ester
(Cy3) or 1-(5-scarboxypentyl)-1'-methylindodicarbocyanine halide Nhydroxysuccinimidyl ester (Cy5), respectively, in the dark for 30 min at 4 °C in a total
volume of 20 µl. Excess N-hydroxysuccinimidyl esters were consumed by adding 1 µl of
10 mM lysine and incubating for 10 min at 4 °C in the dark. The three labeled samples
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were combined and brought to a final volume of 450 µl with 400 µl of 7 M urea, 2 M
thiourea, 4% CHAPS, 10% isopropanol, 5% glycerol (w/v), 5.4 µl Destreak Rehydration
Solution (GE Healthcare), and 2.25 µl of ampholyte pH 3–11 (GE Healthcare).
Two-dimensional Differential In-gel Electrophoresis (2D-DIGE)—Isoelectric focusing of
the combined, labeled samples was conducted using 24-cm 3–10 NL-immobilized pH
gradient (IPG) strips for 6500 Volt-h using an IPGPhor (GE Healthcare). After focusing,
the IPG strips were incubated in 10 ml of 50 mM Tris, pH 8.8, 6 M urea, 30% glycerol,
and 2% SDS containing 50 mg dithiothreitol. The reduced proteins were alkylated by
incubation in the same buffer containing 600 mg of iodoacetamide. Electrophoretic
separation by SDS-PAGE was performed by layering the IPG strips onto 10%
polyacrylamide gels. The Cy2-, Cy3- and Cy5-labeled images were acquired using a
Typhoon Imager (GE Healthcare). Relative quantification of specific gel spots was
determined using the DIA and BVA modules of the DeCyder software.
Protein Identification of Gel Spots by Mass Spectrometry—Specific gel spots were
selected using the Decyder Software and excised from the gel using an x,y robot (ProPic,
Genomic Solutions, Ann Arbor, MI). The gel pieces were trypsin-digested. Mass
spectrometric analysis was performed on the tryptic peptides as previously described
using either a MALDI-TOF/TOF instrument (ABI4700) or a nano LC-MS using a
QSTAR-L mass spectrometer.
Lipopolysaccaride(LPS) Injection – To determine the optimal amount of LPS to induce,
multiple concentrations of LPS were given to Wt mice. The concentrations given are:
saline (no LPS), 5μg/kg, 50 μg/kg, 500 μg/kg, and 5 mg/kg. The LPS was diluted with
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saline and injected intraperitonially. The optimal dose was determined to be 500 μg/kg
and this is the dosage that was used.
Quantitative Western Blotting—The relative quantities of two plasma proteins,
haptoglobin and hemopexin were determined. Plasma proteins from individual Wt and
ASGR-/- mice at 0 hrs and 24 hrs after LPS was injected were separated by SDS-PAGE
and electrophoretically transferred to Immobilon-FL PVDF membranes (Millipore). For
hemopexin detection, 1 µg of plasma proteins was loaded onto a 4–12% Bis-Tris gel. For
haptoglobin, 10 µg of plasma proteins was loaded onto 4–12% Bis-Tris gels. The plasma
was separated using MOPS Running Buffer for all gels (Invitrogen). Following
electrophoretic transfer membranes were incubated in 0.1% casein (Hammersten grade,
BDH Chemicals) for 1 h to block nonspecific binding during incubation with antibodies.
The relative quantity of each protein in each sample was determined by incubating the
membranes overnight at 4 °C with the appropriate antibody in 25 ml of PBS. The
dilutions were: rabbit anti-mouse haptoglobin (Life Diagnostics) 1:20,000 and rabbit antirat hemopexin (Life Diagnostics) 1:2,500. The membranes were washed three times for
10 min at 25 °C with 0.01% Tween 20 in PBS and incubated for 1 h at room temperature
with IReDye800 labeled goat anti-rabbit IgG (Rockland). After washing three times for
10 min at 25 °C with 0.01% Tween 20 in PBS, a LICOR Odyssey was used to scan and
quantitate the relative amount of protein in each fraction.
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Results
Multiple proteins are elevated in ASGR-/- during APR. In unperturbed ASGR-/plasma, multiple APPs are elevated; however, ASGR-/- mice do not have elevated CRP
and therefore, are not undergoing an APR [71]. Once an APR is induced in ASGR-/mice, we expect the APPs to further increase in concentration compared to unperturbed
ASGR-/- mice. To visualize changes in plasma protein concentrations, we used 2D-DIGE
to separate the cyanine-labeled proteins into individual components and scanned the gel
with a Typhoon Imager. In the false-colored image, elevated ASGR-/- sham proteins
appear green, elevated ASGR-/- CLP proteins appear blue, and elevated Wt CLP proteins
appear red. Proteins with equal amounts in all samples, such as albumin, appear white.
Multiple proteins that are elevated in unperturbed ASGR-/- further elevate in
ASGR-/- CLP plasma (Figure 1). Tryptic peptides from multiple proteins were identified
by tandem mass spectrometry. The identities of these proteins, labeled 1-7 are listed in
Table 1. The column ASGR-/- CLP/ASGR-/- sham contains data showing the elevation
of proteins during the APR compared to the control group. The column labeled ASGR-/CLP/Wt CLP compares the elevation of ASGR-/- APR to Wt APR animals. Proteins do
elevate during the APR in ASGR-/- mice compared to the sham. We identified a total of
seven elevated proteins by mass spectrometry: ceruloplasmin, inter-alpha trypsin
inhibitor heavy chain 4, hemopexin, alpha-1-acid glycoprotein, haptoglobin, SAP and
complement 3. Two of the proteins previously identified in unperturbed ASGR-/plasma, haptoglobin and SAP further elevate in ASGR-/- CLP plasma. Haptoglobin and
SAP elevate 2.22 and 3.99-fold respectively, in ASGR-/- CLP mice compare to ASGR-/sham mice. Hemopexin is not significantly elevated in unperturbed ASGR-/- plasma.
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Haptoglobin, SAP, and hemopexin elevate significantly in ASGR-/- plasma compared to
Wt CLP plasma. Haptoglobin elevated 7.34-fold, SAP elevated 4.88-fold and hemopexin
elevated 3.75-fold in ASGR-/- CLP plasma, compared to Wt CLP plasma.
While the 2D-DIGE technique is useful for initial identification of proteins that
are elevated in the plasma, the 2D gel only gives us information about specific isoforms.
Many of the isoforms identified are elevated, but other isoforms in the group are not
elevated. Additional methods are necessary to establish whether total protein
concentrations increase. In addition, only three samples can be run on a 2D-DIGE gel at
a time so the ultimate comparison of Wt sham, ASGR-/- sham, Wt CLP, and ASGR-/CLP cannot be conducted. Using an alternative method to induce an APR, we have
compared haptoglobin and hemopexin levels before an APR and 24 hrs after the
induction of an APR.
Haptoglobin and hemopexin are elevated in ASGR-/- during the APR. LPS, found in
the outer membrane of Gram-negative bacteria, acts as an endotoxin and induces an APR.
Several dilutions of LPS were used to determine the optimal dose of LPS to induce an
acute phase response. The concentrations of LPS injected intraperitonially into our mice
are saline with no LPS, 5 μg/kg, 50 μg/kg, 500 μg/kg, and 5 mg/kg (Figure 2).
Quantification of haptoglobin was used to determine whether an APR was initiated, and
we found that 500 μg/kg and 5 mg/kg both caused a dramatic increase in haptoglobin
within 24 hrs. For our studies, we used 500 μg/kg to induce an APR in our mice.
Based on the 2D-DIGE gel, haptoglobin and hemopexin are both significantly
elevated in ASGR-/- CLP plasma compared to Wt CLP plasma. We further investigated
these two proteins using quantitative western blotting. Plasma was collected from Wt
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and ASGR-/- mice, termed 0 hrs, the mice were injected with LPS, and 24 hrs following
the injection, plasma was collected and analyzed.
Similar to what we had seen previously, before LPS was injected, haptoglobin
was elevated 3.4-fold. After the APR was induced with LPS, haptoglobin increased 21.3fold in Wt plasma, but only 7.54-fold in ASGR-/- plasma. The relative quantities of
haptoglobin in Wt and ASGR-/- mice were not significantly different at 24 hrs.
Hemopexin was slightly increased in ASGR-/- mice before injection. Following the LPS
injection, hemopexin elevated 2.67-fold in Wt plasma, but only 1.35-fold in ASGR-/plasma. The relative quantities of hemopexin were not significantly different at 24 hrs
either. Haptoglobin and hemopexin in Wt mice elevates more significantly that in
ASGR-/- plasma, and we propose this increase is due to decreased clearance.
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Discussion
During the APR, there is an increase in a large number of proteins, many of which
are glycoproteins. There are two types of APPs, positive APPs those that increase at least
25% during the APR and negative APPs, those that decrease at least 25% during the APR
[75]. We have previously shown in ASGR-/- plasma, many proteins are elevated, and
these proteins are mainly positive APPs [71]. Based on the identity of these proteins, we
would expect them to further elevate during the APR. By 2D-DIGE, we have shown
multiple proteins elevate during the APR and two of the proteins that are elevated in
unperturbed ASGR-/- plasma, haptoglobin and SAP, further increase in ASGR-/- mice
undergoing an APR.
Many of the proteins elevated in ASGR-/- plasma are APPs, and since these
proteins are already elevated in ASGR-/- plasma, when these animals undergo an APR,
these proteins will further elevate due to increased synthesis. However, if increased
synthesis and decreased clearance by the ASGR both account for the elevation of these
proteins, we should not see as dramatic of an increase in ASGR-/- CLP plasma. Using
LPS to induce an APR, we have found that there is an elevation of haptoglobin and
hemopexin in Wt and ASGR-/- plasma, but the increase is not as dramatic as in ASGR-/plasma. Haptoglobin increases 21-fold in Wt plasma, and it only increases 7-fold in
ASGR-/-. Similarly with hemopexin, in Wt plasma during the APR, hemopexin elevates
3-fold and in ASGR-/- plasma, hemopexin does not elevate in ASGR-/- plasma. This
strongly suggests that in addition to elevated synthesis, decreased clearance accounts for
the striking increase in APPs.
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We have previously shown the ASGR clears glycoproteins bearing Siaα2,6Gal
[71]. Many of the proteins found to be elevated during the APR bear Siaα2,6Gal.
Treichel et al [35] previously showed in HepG2 cells, the ASGR becomes inactive within
hours of exposure to IL-2 and ultimately is down regulated, suggesting the ASGR may
play a role in regulating APP concentrations during the APR. Additionally, it has been
shown the transferase that adds Sia to Gal, α2,6-sialyltransferase is up regulated and
nearly all terminal Gal is capped with Sia [72, 73]. Twenty-four hours following the
induction of an APR, the concentration of proteins in Wt and ASGR plasma are similar,
despite the dramatic differences seen in unperturbed animals. This suggests in the Wt
mice, the function of the ASGR has changed, becoming more similar to ASGR-/- mice.
Combined, this information strongly suggests during the APR, decreased clearance of
glycoproteins by the ASGR aids in elevating the concentration of proteins bearing
Siaα2,6Gal.
We postulate that in addition to increased synthesis, decreased clearance by the
ASGR during the APR elevates the APPs. Based on previous literature, the ASGR
responds within the first few hours of an APR by phosphoylating the ASGR, rendering it
inactive, and multiple hours later, synthesis of the receptor is decreased. Both of these
events would result in decreased clearance by the ASGR. Future experiments include
determining the binding activity of the ASGR in unperturbed animals and throughout the
APR to elucidate the precise function of the ASGR throughout the APR.
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APR, acute phase response; APP, acute phase protein; ASGR, asialoglycoprotein
receptor; Sia, sialic acid; Gal, galactose; GalNAc, N-acetylgalactosamine; CLP, cecal
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Tables
Table 1. Identification of proteins increased in plasma from ASGR–/– CLP mice.
Spots identified as being elevated in the plasma of ASGR–/– CLP mice, indicated by the
numbers 1–7 in Fig. 1, were identified by tandem mass spectrometry of tryptic fragments.
The identification and fold increase in level of plasma proteins from ASGR–/– CLP as
compared to ASGR-/- and Wt CLP mice are indicated for individual spots in each group.
Protein

Location

GI Number

Fold change
(-/-)CLP/
(-/-)sham
2.72
3.18
1.41
4.41

Fold change
(-/-)CLP/Wt
CLP
1.09
3.09
2.65
1.11

Ceruloplasmin
inter-alpha
trypsin
inhibitor heavy
chain 4

1
2

38614350
38614350

Hemopexin
alpha-1-acid
glycoprotein

3
4

22022646
109548

1.29
1.88

3.75
4.13

Haptoglobin
SAP
Complement
C3

5
6
7

2144486
54045

2.22
3.99
3.17

7.34
4.88
3.02
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Figures
Figure 1. Multiple proteins are elevated in ASGR-/- during the APR. Equal amounts
of plasma from Wt CLP, ASGP-/- CLP, and ASGR-/- CLP were labeled with Cy2, Cy3,
and Cy5, respectively. The cyanine-dye labeled samples were processed, separated by
2D-DIGE, and protein spots were identified by mass spectrometry as previously
described. Proteins appearing in green are highest in the ASGR-/- sham, proteins in blue
are highest in ASGR-/- CLP, and proteins in red are highest in Wt CLP. Proteins that
appear white are equal in all three samples. The protein identifications, labeled 1-7 can
be found in Table 2. The protein spots identified include two proteins identified in
unperturbed ASGR-/- mice, haptoglobin and SAP, as well as five additional proteins,
ceruloplasmin, inter-alpha trypsin inhibitor heavy chain 4, hemopexin, alpha-1-acid
glycoprotein and component C3.
Figure 2. Induction of APR with LPS. Four different concentrations of LPS, 5 μg/kg,
50 μg/kg, 500 μg/kg, and 5 mg/kg were injected intraperitonially into Wt mice to
determine the optimal concentration of LPS to inject to induce an APR. The relative
quantity of haptoglobin was used to determine whether an APR was induced. An APR
was induced with all 4 doses; The 500 μg/kg and 5 mg/kg doses caused over a 20-fold
increase in haptoglobin. The dosage chosen for further experiments was 500 μg/kg.
Figure 3. Haptoglobin and hemopexin elevated in ASGR-/- during the APR, but not
as dramatically as Wt. Plasma was collected at time 0, 500 μg/kg of LPS was injected
intraperitonially into Wt and ASGR-/- mice, and the animals were sacrificed 24 hours
later and blood was collected. Quantitative western blotting was conducted on the
plasma, and the integrated intensity was used to determine relative amounts of
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haptoglobin and hemopexin. Haptoglobin is elevated 3.4-fold in the 0 hr ASGR-/plasma. At 24 hours, haptoglobin is elevated 7.54-fold in ASGR-/- plasma and 21.3-fold
in Wt plasma (p=0.0002). Hemopexin is slightly elevated at 0 hrs in ASGR-/- plasma,
but does not further elevate after 24 hrs in ASGR-/-. Hemopexin elevates 2.67-fold in Wt
plasma.
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Figure 1.
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Figure 3.
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Chapter 4
The mannose/GalNAc-4-SO4 receptor and asialoglycoprotein receptor regulate
steroid hormone levels
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Introduction
Luteinizing hormone (LH) bears unique N-linked oligosaccharides that terminate
with the sequence SO4-4-GalNAcβ1,4GlcNAc (GalNAc-4-SO4) [7-10]. Two β1,4Nacetylgalactosaminyltransferases (βGT3 and βGT4) that may account for the proteinspecific modification of LH and other glycoproteins bearing this modification have
recently been cloned [76-78] and found to have the expected protein specificity [79]. Two
GalNAc-4-sulfotransferases, GalNAc-4-ST1 and GalNAc-4-ST2, have also been cloned
[80-82] and can selectively modify the terminal β1,4-linked GalNAc on N-linked
oligosaccharides [83]. We recently demonstrated that following ablation of GalNAc-4ST1, the predominant form of GalNAc-4-ST in the pituitary, sulfation of LH
oligosaccharides is abolished and there is a marked increase in GalNAc bearing α2,6linked sialic acid (Sia) on LH. The half-live for endogenous LH in the blood increases
from 7.2 min in Wt mice to 10.1 min in GalNAc-4-ST1-/- mice. Furthermore, there are
significant elevations in levels of LH, estrogen, and testosterone in the GalNAc-4-ST1-/mice demonstrating that terminal glycosylation determines the half-life and as a result the
potency of LH in vivo [63].
We demonstrated that the Cysteine-rich domain of the Mannose/GalNAc-4-SO4Receptor (MR), a ricin-type beta-trefoil, binds terminal GalNAc-4-SO4 on
oligosaccharides such as those found on LH [50] and that the asialoglycoprotein receptor
(ASGR) binds oligosaccharides terminating Siaα2,6GalNAcβ1,4GlcNAc
(Siaα2,6GalNAc) [33].

Lee et.al. [52] reported that ablation of MR did not increase

the half life of radiolabeled porcine LH even though the half life of the neoglycoprotein
S4GGnM-BSA was increased in MR-/- mice. In contrast, Mi et al. [53] reported a slight
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increase in the half life of bovine LH and reduced implantation in heterozygous MR
mice. Thus, while MR and the ASGR are able to bind oligosaccharides terminating with
GalNAc-4-SO4 and Siaα2,6GalNAc, respectively, their role in clearing endogenous LH
remains to be definitively established.
We recently established a method to examine the time course for clearance of
endogenous LH in mice and have used this method to determine if MR and/or ASGR
determine the half life for endogenous LH. The clearance of endogenous LH was
examined in MR-/-, ASGR-/-, and MR-/-ASGR-/-. In addition, hormone levels and
mRNA levels for various genes were compared in mice with one or both receptors
ablated to determine if there is a physiologic impact. The MR does indeed account for
the clearance of endogenous LH in the mouse. Furthermore, changes in hormone levels
and steady state levels of mRNAs indicate that both the MR and ASGR contribute to
regulation of LH levels in vivo.
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Methods
Serum Preparation and tissue collection – Serum was collected by terminal
cardiac puncture. Mice were anesthetized with ketamine (87mg/kg) and xylazine (13
mg/kg), and blood was collected and allowed to clot for 30 min in serum separator tubes
(BD). The serum was separated by centrifugation for 30 min at room temperature.
Serum was stored at -80oC. Tissues, including pituitary and testes were collected from the
same mice and stored at -80oC for further use.
Hormone Assays – Quantification of LH, FSH, and testosterone was conducted at
University of Virginia Ligand Core. An immunoradiometric assay (IRMA) is used to
quantify LH and a radioimmunoassay (RIA) to quantify FSH and testosterone.
Clearance of endogenous LH – Clearance of endogenous LH in castrated male
mice was carried out as described previously [53]. Mice were anesthetized with ketamine
and xylazine. A baseline sample of blood, 75 µl, was drawn, then 10 µg of Acyline
(Woods Assay, Inc.), was injected into the retro-orbital sinus. Additional samples of 75
µl were collected at 5 and 10 min, and 150 µl was collected at 20 min. At 30 min, the
mouse was bled by cardiac puncture. The mice were kept warm on a heating pad for the
duration of the experiment, and after each blood draw, 200 µl of warm saline was
injected intraperitoneally.
Castration – Mice were anesthetized with ketamine and xylanine. The scrotum
was shaved and cleaned with isopropanol and povidone. A 2 inch midline incision was
made in the scrotum, the tunica was pierced, and the testis was pushed out with gentle
pressure. The spermatic artery was cauterized and cut to remove the testis. The
epididymis, deferential vessels, and ductus were placed back in the tunica. Several drops
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of lidocaine were placed in the incision, and the incision was closed with 6-0 Ethilon
sutures.
RNA Isolation – RNA was isolated from individual pituitaries using MagMAX-96
Total RNA Isolation Kit (Ambion). Each pituitary was incubated in 100 µl
Lysis/Binding Solution for 2 h at room temperature, and then homogenized using a 20gauge needle and 1 ml syringe. Homogenized samples were transferred to a 96-well
Processing Plate, 60 µl of 100% isopropanol was added, and the plate was shaken for 1
min on an orbital shaker. Bead mix containing RNA binding beads and Lysis/Binding
Enhancer, 20 µl, was added to each sample and shaken for 5 min. The RNA binding
beads were captured on the magnetic stand for 3 min and the supernatant was aspirated
and discarded. The beads were washed once with 150 µl Wash I and once with150 µl
Wash II. Nucleic acids were released from the binding beads with 50 µl diluted
TURBODNase to degrade genomic DNA. RNA was rebound to the beads using 100 µl
RNA Rebinding Solution. The beads were captured and the supernatant was aspirated
and discarded. The beads were then washed twice with 150 µl Wash II, and the beads
were dried. Finally, 30 µl of Elution Buffer was added to each sample and shaken
vigorously. The supernatant containing the RNA was collected for further use.
For isolation of RNA from testes, tissue was homogenized in 1 ml TRIZOL
Reagent. The homogenized samples were incubated for 5 min at room temperature to
dissociate nucleoprotein complexes. Chloroform, 0.7 ml, was added and the mixture was
shaken vigorously for 15 sec then incubated at room temperature for 3 min. Phase
separation was completed by centrifuging at 13,000 x g for 15 min at 4oC, and the
aqueous phase was collected. The RNA was precipitated with 0.5 ml isopropanol,
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incubated on ice for 15 min, and centrifuged at maximum speed for 30 min. RNA
cleanup was done using RNeasy Mini Kit (Qiagen) exactly as indicated in the
manufacturer’s protocol. Briefly, the precipitated RNA was dissolved in 100 µl RNasefree water, ethanol was added, and the mixture was put onto an RNeasy Mini spin
column. The column was washed and RNA eluted with 100 µl RNase-free water.
Quantification of RNA from both pituitary and testes was determined using a Nanodrop
(Thermo Scientific).
Quantitative RT-PCR (qPCR) – Template cDNA was generated using Omniscript
Reverse Transcription kit (Qiagen). On ice, template RNA was thawed and fresh master
mix was prepared. For the master mix, 1 µl 10x Buffer RT, 1 µl dNTP Mix, 1 µl OligodT primer, 0.5 µl RNase inhibitor and 0.5 µl Omniscript Reverse Transcriptase were
mixed together. To the master mix, 1 µg template RNA was added, and the final volume
was brought to 10 µl with RNase-free water. The mixture was incubated at 37oC for 1 h,
then diluted 5-fold, to a final volume of 50 µl. The qPCR reaction was set up in triplicate
for each sample with 2 µl diluted cDNA, 1 µM primers, 10 µl 2x Sybr Green Mix, and
water to a final volume of 20 µl. The primer sequences used listed in Table 1. The qPCR
was run on an ABI 7500 using standard conditions. The data was imported into Prism
and analyzed.
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Results
The MR mediates the rapid clearance of secreted LH from the blood.
The detailed structures of the N-linked oligosaccharides on murine (m) LH have
not to date been examined. We have, however, shown that LH from the pituitary of wild
type (Wt) mice contains significant amounts of terminal GalNAc-4-SO4 and is the major
glycoprotein in the pituitary bearing such structures [9, 63]. Furthermore, we determined
that there is little terminal GalNAc on mLH and relatively little Siaα2,6GalNAc
suggesting that, as in other mammalian species, N-linked oligosaccharides terminating
with GalNAc-4-SO4 predominate on mLH. Male mice were castrated in order to elevate
the circulating levels of LH. Blood was withdrawn at time 0 and at 5, 10, 20, and 30 min
after injection of Acyline, a GnRH antagonist that acutely blocks secretion of LH. The
amount of mLH remaining in the blood at each time point was determined by IRMA.
Examples of clearance curves obtained for Wt, MR-/-, ASGR-/-, and MR-/-ASGR-/mice are shown in Figure 1, Panels A-D.
The half life for clearance of endogenous mLH increases from 8.4 min to 15.6
min in MR-/- mice as compared to Wt mice (Fig.1 Panels B and E). In contrast ablation
of the ASGR does not change the half life of mLH as compared to Wt mice (Fig.1 Panels
B and E). The increase in the half life of mLH in MR-/- mice indicates that MR does
indeed account for the rapid clearance of LH from the blood following GnRH stimulated
secretion. Since there is no increase in the half life of mLH in ASGR-/- mice, the ASGR
must not account for much, if any of the clearance of LH in Wt mice. In addition, the
vast majority of LH must bear multiple oligosaccharides that terminate with one of more
GalNAc-4-SO4 moieties. Mice that have had both receptors ablated, MR-/-ASGR-/53

mice (Fig 1.D), also remove LH from the circulation at a slower rate than Wt mice. The
mean half life of 11.6 min is significantly longer than in Wt mice, p=0.042, but not
significantly different from the half life seen in MR-/- mice. The half life obtained for
LH clearance in MR-/-ASGR-/- mice also supports the conclusion that recognition of
terminal GalNAc-4-SO4 on LH by MR-/- is the predominant if not exclusive basis for
the rapid clearance of LH from the blood.
Circulating LH is elevated in MR-/-, ASGR-/-, and MR-/-ASGR-/- mice.
GalNAc-4-ST1-/- mice modify the GalNAc termini on LH N-linked
oligosaccharides with α2,6-linked Sia rather than SO4 [63]. LH bearing terminal
Siaα2,6GalNAc is likely cleared from the circulation by the ASGR but at a slower rate
than LH bearing GalNAc-4-SO4. As a result the half life increases from 7.2 min in Wt to
10.1 min in GalNAc-4-ST1-/- mice. Levels of LH and testosterone are increased in
GalNAc-4-ST1-/- mice and they have enlarged seminal vesicles. We examined MR-/-,
ASGR-/-, and MR-/-ASGR-/- mice for changes in LH, FSH, testosterone, and seminal
vesicle size (Fig. 2).
LH levels (Fig. 2A) are significantly elevated 3.5-fold in MR-/-, 2.5-fold in
ASGR-/-, and 2.9-fold in MR-/-ASGR-/- mice compared with Wt mice, p<0.005 for all
three genotypes. In contrast, there were no significant differences in FSH levels (Fig.
2B) in any of the genotypes. There is a corresponding increase in testosterone levels in
all three genotypes (Fig. 2C), 2.9-fold in MR-/-, 4.7-fold in ASGR-/-, and 3.4-fold in
MR-/-ASGR-/- mice as compared to Wt mice. The size of the seminal vesicles, which is
determined by testosterone levels, is increased in all three genotypes (Fig. 2D).
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As with the GalNAc-4-ST1-/- mice, a reduced rate of LH clearance is associated
with an increase in LH and testosterone in MR-/- and MR-/-ASGR-/- mice. The increase
in LH and testosterone in the ASGR-/- mice is unexpected since the rate of LH clearance
is not altered as compared to Wt. Regulation of LH and testosterone levels in vivo is
complex and involves the hypothalamus, pituitary, and gonad; i.e. the HPG axis [84].
GnRH produced by the hypothalamus stimulates the production and release of LH by the
pituitary and the released LH stimulates production of testosterone by the testis.
Testosterone in turn regulates the production and release of GnRH. It is possible that the
ASGR mediates the clearance of glycoproteins, other than LH itself, that modulate the
production of and release of LH by gonadotrophs in the pituitary. The increased levels of
LH and testosterone in MR-/-, ASGR-/-, and MR-/-ASGR-/- mice indicates that the HPG
axis cannot fully compensate for the changes that result from reduced rates of clearance
by these receptors. We examined steady state mRNA levels for a number of proteins in
the pituitary and testis in order to determine how the HPG axis is responding to the
altered rates of clearance in the receptor deficient mice.
Glycoprotein hormone and glycosyltransferase expression in the pituitary.
We examined the steady state mRNA levels for LH, FSH, and TSH beta subunits
in individual pituitaries for all three genotypes using quantitative RT-PCR. LHβ levels
are elevated 1.3 fold in MR-/- mice and 2.0 fold in ASGR-/- mice (Fig.3A). The
increased levels of LHβ mRNA in the ASGR-/- mice is striking since neither FSHβ nor
TSHβ differ from Wt mice in MR-/- or ASGR-/- mice (Fig. 3B and C). The 1.3 fold
increase in LHβ in MR-/- mice suggests that the reduced rate of clearance rather than
increased synthesis accounts for the elevated LH in the blood whereas the 2.0 fold
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increase in LHβ in ASGR-/- mice suggests that increased synthesis accounts for the
elevated levels of circulating LH.
Steady state levels of mRNA for βGT3, βGT4, GalNAc-4-ST1, and α2,6SiaylT
were determined for the same genotype (Fig. 4). GalNAc-4-ST1 (Panel A), and
α2,6SiaylT (Panel B) increased 1.6 and nearly 2.0 fold, respectively, in MR-/- and
ASGR-/- mice. In contrast, βGT3 and βGT4 message levels decreased 10-20% in the
same mice (Panel C and D). The changes in GalNAc-4-ST1, and α2,6SiaylT suggest that
they are regulated in parallel to LHβ in these mice but that this is not the case for either
βGT3 or βGT4 message. In contrast to the increases in LHβ message seen in MR-/- and
ASGR-/- mice, LHβ message is reduced in MR-/-ASGR-/- mice (Fig. 3). Similarly the
message levels for both GalNAc-4-ST1 and α2,6SiaylT are lower in MR-/-ASGR-/mice (Fig.4 A and B). TSH also bears N-linked oligosaccharides that terminate with
GalNAc-4-SO4 [8, 9] and TSHβ message is decreased in MR-/-ASGR-/- mice (Fig.3C).
Thus, altering clearance by ablation of both receptors also affects TSH expression in
these mice.
Gene expression in the testis of MR-/-, ASGR-/-, and MR-/-ASGR-/- mice.
LH serves to regulate the production of testosterone in the testis of male mice.
The expression of a number of genes in the testis is regulated by LH including the LH
receptor (LHR) [85], steroidogenic acute regulatory (StAR) protein [86], activin and
inhibin [87, 88]. Testosterone and activin [89] in turn are known to regulate the
expression of LHβ. Since LH and testosterone are elevated in all three receptor
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knockouts we compared the expression these genes in the testis of MR-/-, ASGR-/- and
MR-/-ASGR-/- mice (Fig. 5).
Despite the elevated levels of LH and testosterone in MR-/- and ASGR-/- mice,
expression of LHR, StAR, 20α-HSD, inhibin, and activin are not significantly changed.
In marked contrast, the expression of each of these genes is increased in the MR-/ASGR-/- mice with 20α-HSD being elevated 12.5-fold and activin and inhibin being
elevated 4.6 and 5.4-fold, respectively (Fig.5). Loss of clearance by both the MR and the
ASGR has a different impact on gene expression in both the testis and the pituitary than
loss of clearance by either receptor individually suggesting that both receptors contribute
to the regulation of the HPG axis in vivo.
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Discussion
LH was the first of the pituitary glycoprotein hormones shown to bear unique Nlinked oligosaccharides terminating with SO4-4-GalNAcβ1,4GlcNAc [7-10]. We
determined that oligosaccharides terminating with GalNAc-4-SO4 are recognized by the
ricin-type beta-trefoil Cysteine rich domain that is located at amino terminus of the MR
and hypothesized that the MR accounts for the rapid clearance of LH from the blood
following its stimulated secretion and that rapid clearance is critical for the function of
LH in vivo [50]. We have taken a genetic approach to determine if the MR does indeed
account for the rapid clearance of LH from the blood and if rapid clearance plays a role in
LH function in vivo. Terminal GalNAc on LH N-linked oligosaccharides synthesized by
mice that have had GalNAc-4-ST1 ablated is not modified with SO4 but is instead
modified with α2,6-linked Sia. LH bearing Siaα2,6GalNAc rather than terminal
GalNAc-4-SO4 is recognized by the ASGR rather than the MR and is cleared from the
blood at a slower rate following secretion, half live of 10.1 vs 7.2 min [63]. Circulating
levels of LH, testosterone, and estrogen are increased in GalNAc-4-ST1-/- mice. Tissues
that are sensitive to testosterone and estrogen, seminal vesicles in males and uteri in
females, are enlarged in GalNAc-4-ST1-/- mice and sexual maturation occurs at an
earlier age. The GalNAc-4-ST1-/- mice demonstrate that the structure of the N-linked
carbohydrates on LH determines which receptors mediates LH clearance and as a
consequence the amount of estrogen and testosterone produced in response to the LH.
The half life of endogenous LH in MR-/- mice increased from 8.4 min to 15.6
min demonstrating that the MR indeed accounts for the rapid clearance of LH from the
blood and that the vast majority, if not all, of the LH in Wt mice is modified with
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terminal GalNAc-4-SO4 on at least two N-linked oligosaccharides. Earlier conclusions
that the half life of LH was not altered in MR-/- mice were based on the injection of
exogenous, radiolabeled porcine LH [52] and may not accurately reflect the half life of
the endogenous hormone for a number of reasons. The amount of radiolabeled LH
injected would have resulted in micromolar concentrations of LH in the mouse
potentially saturating the MR. In any case, the half life of 15.6 min in MR-/- is consistent
with clearance of the hormone by renal filtration. The absence of any change in the half
life of endogenous LH in ASGR-/- mice indicates that there is not sufficient terminal
GalNAc or Siaα2,6GalNAc on endogenous LH for the ASGR to contribute to the
clearance of LH. Male MR-/- mice, like GalNAc-4-ST1-/- mice [63], have elevated levels
of LH and testosterone. In addition their seminal vesicles, which are responsive to
testosterone, are larger than those of Wt males. The increase in LH and testosterone
levels is significant and indicates that the HPG axis cannot fully compensate for the
changes resulting from a prolonged LH half life.
The half life of endogenous LH in ASGR-/- mice is not increased; however, like
MR-/- mice the levels of LH and testosterone are elevated. A further indication that the
increased levels of LH and testosterone are physiologically significant comes from the
increased size of the seminal vesicles. Since the half life of LH is not altered in ASGR-/mice, the increased levels of LH and testosterone indicate that the half life of another
component of the HPG axis that influences LH levels is likely altered and may be
modified with Siaα2,6GalNAc. The half life of endogenous LH in MR-/-ASGR-/- mice,
like that in MR-/- mice, is prolonged and the levels of LH and testosterone are increased.
Regulation of the HPG axis is complex but serves to maintain very precise levels of
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hormone in the blood. LH and testosterone levels are not only increased in MR-/-,
ASGR-/-, and MR-/-ASGR-/- mice but also are more variable. This suggests that in the
absence of clearance by either the MR, ASGR, or both receptors it is more difficult to
maintain hormone levels at the precise levels required. Furthermore, the differences in
expression of mRNAs in the pituitary and testis in the MR-/-, ASGR-/-, and MR-/ASGR-/- mice indicate that the manner in which LH and testosterone levels are being
maintained in the different receptor knockouts is not the same and likely reflect the HPG
axis attempting to compensate for the changes produced by altering clearance rates.
Our current studies confirm that N-linked structures terminating with GalNAc-4SO4 predominate on murine LH and demonstrate that the MR mediates the rapid
clearance of LH from the blood. Furthermore, clearance by the MR is an important
component of HPG axis regulation and maintenance of LH and testosterone levels in
vivo. Our studies also implicate the ASGR in the maintenance of LH and testosterone
levels in vivo; however, further studies will be required to identify the glycoproteins
recognized by the ASGR.
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MR, mannose/GalNAc-4-SO4 receptor; ASGR, asialoglycoprotein receptor; bGT, b1,4
N-acetylgalactosyaminyltransferase; GalNAc, N-acetylgalactosamine; ST,
sulfotransferase; Sia, sialic acid; Wt, wild-type; IRMA, immunoradiometric assay; RIA,
radioimmunoassay; GnRH, gonadotropin releasing hormone; LH, luteinizing hormone;
FSH, follicle-stimulating hormone; TSH, thyroid stimulating hormone; LHR, LH
receptor; StAR, steroidogenic acute regulatory protein; 20α-HSD, 20 alpha
hydroxysteroid dehydrogenase; HPG, hypothalamic-pituitary-gonadal
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Tables.
Table 1. qPCR primers used for LHβ, FSHβ, TSHβ, LHR, StAR, 20αHSD, Activin,
Inhibin reactions
Primer

Sequence

LH F

GTCAACGCAACTCTGGCCGCAGAGAA

LH R

GCACACTGGCTGAGGCACAGGAGGCAA

FSH F

GCTTTCCCCAGAAGAGACAGCTGA

FSH R

CTACTGAGATGGTGATGTTGGTCAA

TSH F

GGAGAGAGTGTGCCTACTGCCTGA

TSH R

CCTGAGAGAGTGCATATTTGGGAA

LHRF

ACATAACCACCATACCAGGG

LHRR

ACTGTGCATCTTCTCCAGG

StARF

ATCACTCATGAGCTGGCTGCG

StARR

GTGAGTTTAGTCTTGGAGGG

20 HSDF

ACTTCCCATCGTCCAGAGTTGG

20 HSDR

AGCTCATTCCCTGGCTTCAGAG

ActivinF

ACGGGTATGTGGAGATAGAGG

ActivinR

AGTGCAGTGTCTTCCTGGC

InhibinF

ACAGGACCTCTGAACCAGAG

InhibinR

AGTGAAGAGGCCTTCCTCAG
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Figures.
Figure 1. Clearance of endogenous LH is slower in MR-/- and MR-/-ASGR-/- mice.
Mice were castrated to maximize LH five days prior to clearance studies. Plasma was
collected retroorbitally prior to and following a 10 µg injection of acyline at times 0, 5,
10, 20, and 30 min. Plasma LH concentrations were determined by immunoradiometric
assay and analyzed using Prism in (A) Wt, (B) MR-/-, (C) ASGR-/-, and (D) MR-/ASGR-/-. The half-life of LH (E) is nearly doubled, 8.4 min compared to 15.6 min
(p=0.0228), in MR-/- mice. The half-life of LH is also prolonged in MR-/-ASGR-/mice, 11.6 min (p=0.0419); however, not as significantly as in MR-/- mice.
Figure 2. Levels of LH and testosterone, but not FSH are elevated in MR-/-, ASGR/- and MR-/-ASGR-/-. Plasma was collected from adult male Wt, MR-/-, ASGR-/-, and
MR-/-ASGR-/- mice. Circulating LH levels (A) were determined using an IRMA and
analyzed using a parametric t-test. LH levels are significantly elevated in all three
genotypes compared to Wt (p<0.005). Testosterone levels (B) were determined by RIA
and analyzes using a non-parametric t-test, Mann-Whitney since testosterone does not
follow a normal distribution. Testosterone is significantly elevated in all three knockout
genotypes compared to Wt (p<0.05). FSH levels (C) were determined by RIA, and there
is no significant difference between Wt and any of the knockout genotypes. Seminal
vesicles (D) are a target of testosterone and are enlarged significantly in all three
genotypes, but most significantly enlarged in MR-/-ASGR-/-mice.
Figure 3. The expression of LHβ, FSHβ, and TSHβ decreases in the pituitary of
MR-/-ASGR-/- mice. Relative mRNA transcript levels of LHβ, FSHβ, and TSHβ were
determined using qPCR. Pituitaries from Wt, MR-/-, ASGR-/-, and MR-/-ASGR-/- mice
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were collected and the mRNA from each knockout was compared to Wt using an ABI
7500 PCR system. The expression levels were normalized to 18s transcript levels. LHβ
expression (A) doubles in ASGR-/- mice (p<0.0001), but declines 1.7 fold in MR-/ASGR-/- mice (p=0.0059) FSHβ expression (B) remains unchanged in MR-/- and
ASGR-/- mice, but declines 1.7 fold in MR-/-ASGR-/- (p=0.0129). TSHβ mRNA
expression (C) declines 3.5 fold in MR-/-ASGR-/- (p<0.0001).
Figure 4. Alterated transcription of GalNAc-transferases 3 and 4, GalNAc-4sulfotransferase, and α2,6-sialyltransferase. Individual pituitaries were isolated and
the relative mRNA levels in Wt, MR-/-, ASGR-/- and MR-/-ASGR-/- compared to Wt
were determined using qPCR. The expression of GalNAc-transferase 3 (A) declines 1.6fold in MR-/- and ASGR-/- mice (p=0.0102, 0.0165) and the expression of GalNActransferase 4 (B) declines 1.44-fold in MR-/- and MR-/-ASGR-/- (p<0.01). The
expression of GalNAc-4-sulfotransferase significantly increases in MR-/- (p=0.0014) and
ASGR-/- (p<0.0001). The expression of α2,6-sialyltransferase changes similar to that of
LHβ. There is a significant increase in the MR-/- and ASGR-/- pituitaries (p=0.0023,
0.0002) and a 4-fold decrease in the MR-/-ASGR-/- pituitaries (p<0.0001).
Figure 5. Transcription of LHR, StAR, 20αHSD, Activin and Inhibin increases in
the testes of MR-/-ASGR-/-. Testes were collected and processed individually to isolate
mRNA from each testis. Relative mRNA transcript levels of LHR, StAR, 20αHSD,
activin, and inhibin were determined using qPCR. In MR-/-ASGR-/- testes, LHR
expression (A) elevates 1.9 fold (p=0.0051), StAR expression (B) elevates 2.2 fold
(p=0.0002), and 20αHSD expression (C) elevates 13 fold (p<0.0001), activin expression
(D) elevates 4.2 fold (p=0.0008), inhibin expression (E) elevates 5.7 fold (p=0.0021).
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Chapter 5
Regulation of the mannose/GalNAc-4-SO4 receptor and asialoglycoprotein
receptor during pregnancy
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Introduction
A number of glycosylated hormones bear N-linked carbohydrate structures that
are selectively modified with β1,4-linked N-acetylgalactosamine (GalNAc) [90]. The
terminal GalNAc on luteinizing hormone (LH) is further modified with SO4 to produce
the unique terminal sequence SO4-4-GalNAcβ1,4GlcNAcβ1,2Man (GalNAc-4-SO4) [710, 80-82]. Other glycoproteins such as glycodelin in humans and certain prolactin like
proteins (PLP) in rodents that are produced during pregnancy are modified with terminal
α2,6-linked sialic acid (Sia) to generate another unique terminal sequence on their Nlinked oligosaccharides, Siaα2,6GalNAcβ1,4GlcNAcβ1,2Man (Siaα2,6GalNac) [12, 91].
Glycoproteins bearing terminal GalNAc-4-SO4 or Siaα2,6GalNAc are recognized by two
highly abundant receptors located in endothelial cells [40] and parenchymal cells [14] of
the liver, respectively. Glycoproteins bearing oligosaccharides terminating with
GalNAc-4-SO4 are bound by the ricin-type beta-trefoil domain of the Mannose/GalNAc4-SO4-receptor (MR) [51] whereas glycoproteins bearing oligosaccharides terminating
with Siaα2,6GalNAc are bound by the asialoglycoprotein-receptor (ASGR) [6]and in
both cases are rapidly internalized. As a consequence, glycoproteins bearing either of
these structures have relatively short half-lives when injected into the blood[33, 40].
We recently reported [63] that ablation of the sulfotransferase that mediates
sulfate addition to the β1,4-linked GalNAc on LH, GalNAc-4-ST1, results in LH that
terminates with Siaα2,6GalNAc rather than GalNAc-4-SO4. LH bearing Siaα2,6GalNAc
is cleared more slowly than LH bearing GalNAc-4-SO4. As a consequence circulating
levels of LH are elevated as are levels of testosterone in male mice and estrogen in
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female mice. Thus, the amount of testosterone or estrogen produced in response to LH
can be modulated by altering the carbohydrate structure on the hormone in vivo. In the
current study we have taken a genetic approach to determine the role of the MR and the
ASGR in reproduction in female mice. We have examined male mice deficient for the
MR (MR-/-), the ASGR (ASGR-/-), and both the MR and the ASGR (MR-/-ASGR-/-).
The half-life of LH is increased from 8.4 m to 15.6 m in MR-/- indicating that the MR
does indeed account for the rapid clearance of LH in vivo. Furthermore, the levels of LH
and testosterone are elevated in the MR-/- males. The clearance rate for LH is unchanged
in ASGR-/- male mice; however, ASGR-/- mice also have elevated levels of LH and
testosterone suggesting that other glycoproteins that are cleared by the ASGR may have
an impact on LH levels in vivo even though the half life for LH is unchanged.
We have now examined MR-/-, ASGR-/-, and MR-/-ASGR-/- female mice to
determine what role the MR and ASGR play in reproduction. Our results indicate that
the expression of both receptors is highly regulated during the course of pregnancy. In
addition, in the absence of both receptors pregnant mice are not able to initiate parturition
most likely due to an inability to modulate the levels of progesterone.
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Methods
Ovulatory cycle – The esturs or ovulatory cycle in mice consists of four stages
that can be differentiated by vaginal smears. The stage of estrus cycle was determined
daily by vaginal smear for individual mice over 20 consecutive days. The smears were
stained with methylene blue. The four stages are defined by the major cell type present:
predominantly nucleated epithelial and some cornified epithelial cells in proestrus, only
cornified epithelial cells in estrus, cornified epithelial cells and leukocytes in metestrus,
and predominantly leukocytes in diestrus.
Serum preparation and Tissue collection - Serum was collected by terminal
cardiac puncture. Mice were anesthetized with ketamine (87mg/kg) and xylazine (13
mg/kg), and blood was collected and allowed to clot for 30 min in serum separator tubes
(BD). The serum was separated from cells and clot by centrifugation for 30 min at room
temperature and stored at -80oC until use. Tissues, including pituitary, ovaries and liver
were collected from the same mice and stored at -80oC for further use.
RNA Isolation – For isolation of RNA from liver, tissue was homogenized in 1 ml
TRIZOL Reagent. The homogenized samples were incubated for 5 min at room
temperature to dissociate nucleoprotein complexes. Chloroform, 0.7 ml, was added and
the mixture was shaken vigorously for 15 sec then incubated at room temperature for 3
min. Phase separation was completed by centrifuging at 13,000 x g for 15 min at 4oC,
and the aqueous phase was collected. The RNA was precipitated with 0.5 ml
isopropanol, incubated on ice for 15 min, and centrifuged at maximum speed for 30 min.
RNA cleanup was done using RNeasy Mini Kit (Qiagen) exactly as indicated in the
manufacturer’s protocol. Briefly, the precipitated RNA was dissolved in 100 µl RNase73

free water, ethanol was added, and the mixture was put onto an RNeasy Mini spin
column. The column wass washed and RNA eluted with 100 µl RNase-free water.
Quantification of RNA from both pituitary and testes was determined using a Nanodrop
(Thermo Scientific).
Quantitative RT-PCR (qPCR) – Template cDNA was generated using Omniscript
Reverse Transcription kit (Qiagen). On ice, template RNA was thawed and fresh master
mix was prepared. For the master mix, 1 µl 10x Buffer RT, 1 µl dNTP Mix, 1 µl OligodT primer, 0.5 µl RNase inhibitor and 0.5 µl Omniscript Reverse Transcriptase were
mixed together. To the master mix, 1 µg template RNA was added, and the final volume
was brought to 10 µl with RNase-free water. The mixture was incubated at 37oC for 1 h,
then diluted 5-fold, to a final volume of 50 µl. The qPCR reaction was set up in triplicate
for each sample with 2 µl diluted cDNA, 1 µM primers, 10 µl 2x Sybr Green Mix, and
water to a final volume of 20 µl. The primer sequences used are listed in Table 1. The
qPCR was run on an ABI 7500 using standard conditions. The data was imported into
Prism and analyzed.
Vasectomy - Mice were anesthetized with ketamine and xylanine. The scrotum
was shaved and cleaned with isopropanol and povidone. A 2 cm midline incision was
made in the scrotum, the tunica was pierced, and vas deferens was cut. Several drops of
lidocaine were placed in the incision, and the incision was closed with 6-0 Ethilon suture.
The mice were bred with Wt females to verify the vasectomized mice were sterile.
Pseudopregnancy – Female mice were mated with vasectomized males. The day
a vaginal plug was seen was considered day one of pseudopregnancy. Four days
following identification of the vaginal plug, one group of females was injected with oil
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into the uterine horn. The second group of females was manipulated in the same manner
but not oil was injected. Nine days following identification of the vaginal plug, the two
groups of females were sacrificed. The oil injected females were divided into two
groups, those that had decidua and those that did not. Liver was collected for analysis.
Progesterone injections – Progesterone, 100 μg was injected into Wt females for
6 days. After six days, the females were sacrificed and the livers were collected for
analysis.
Progesterone assay – Progesterone levels in serum were analyzed by a solid-125I
assay according to the manufacturer's protocol (Siemens).
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Results
Comparison of the estrus cycle and hormone sensitive tissues in female Wt,
MR-/-, ASGR-/-, and MR-/-ASGR-/- mice. We previously reported that the MR
accounts for the rapid clearance of LH from the blood following its stimulated release
from the pituitary. In contrast, the ASGR does not appear to contribute to clearance of
LH in mice; however, both MR-/- and ASGR-/- male mice have elevated circulating
levels of LH and testosterone suggesting that the MR and the ASGR both contribute to
the regulation of LH and testosterone levels in vivo. We therefore examined female MR/-, ASGR-/-, and MR-/-ASGR-/- mice for evidence of alterations in the regulation of LH
and estrogen levels.
All three genotypes progress through the stages of the estrus cycle (Fig.1) and are
fertile. The number of cycles occurring over a period of 20 consecutive days for 10
individual mice of each genotype was determined (Fig1.E). The average length of the
estrus cycle in Wt and MR-/- was 5.3 days. In contrast the ASGR-/- and the MR-/ASGR-/- mice have average estrus cycle times of 6.9 and 6.5 days, both of which are
significantly longer than those of Wt mice. Unlike Wt mice, cornified epithelial cells
were typically present even during diestrus in MR-/-, ASGR-/-, and MR-/-ASGR-/- mice.
Other than at the time of ovulation circulating levels of estrogen fall below the
levels of detection with currently available immunoassays. This was true for all three
genotypes, indicating that unlike male mice, female receptor knockout mice do not have
markedly elevated levels of estrogen. The uterus is sensitive to estrogen levels. In
GalNAc-4-ST1-/- mice the uterus was 2.3 fold larger than in Wt mice. The uteri from
Wt, MR-/-, and ASGR-/- mice did not differ in their average weight, whereas the uteri
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from MR-/-ASGR-/- mice weighed on average 0.044 g compared to 0.079 g for Wt mice
(Fig.2). Therefore, neither in MR-/-, ASGR-/-, nor MR-/-ASGR-/- female mice show
evidence of increased estrogen levels as compared to Wt mice.
Hormonal Regulation of the MR and ASGR in mice during pregnancy. The
ASGR and the MR mediate the rapid clearance of glycoproteins bearing N-linked
oligosaccharides with terminal Siaα2,6GalNAcβ1,4GlcNAc [33] and SO4-4GalNAcβ1,4GlcNAc [40], respectively. It has been reported that levels of the ASGR are
increased late in pregnancy in rodents [36]. A number of the prolactin-like proteins
(PLP) produced by the placenta during pregnancy in rodents are selectively modified
with terminal Siaα2,6GalNAcβ1,4GlcNAc [12] and represent the first ligands described
for the ASGR that would not require further modification to be recognized by this
receptor. Since the MR and ASGR may regulate the circulating levels of a number of
different hormones that are critical for the maintenance of pregnancy we examined the
expression of message for these receptors at different stages during pregnancy by qPCR
(Fig.3).
Steady state levels of mRNA for the MR and for both subunits of the ASGR
increase 3-6 fold by day 3.5 of pregnancy (Fig.3). Levels of all three mRNAs continue to
increase until day 12.5. After day 12.5 message levels begin to decline but are still
elevated at post natal day 2. The increase in the steady state levels of message for the MR
and the ASGR is remarkable since both are highly abundant receptors in endothelial and
parenchymal cells of the liver, respectively [23, 40].
Since implantation occurs on day 4 in the mouse [53], the elevated levels of MR,
ASGR-1, and ASGR-2 message on day 3.5 suggest that implantation is not essential for
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at least the initial increase in message levels. This was confirmed by mating female mice
with vasectomized male mice to induce pseudopregnancy. Four days after a vaginal plug
was observed oil was injected in the uterus of one group of female mice and another
group was manipulated but not injected. On day 9 the mice were sacrificed and those
injected with oil were divided into those that had or had not developed decidua. Livers
were collected from each group and message levels were determined (Fig.4). The
message levels for the MR, ASGR-1, and ASGR-2 are increased at least 3 fold in
pseudopregnant mice regardless of the presence or absence of decidual tissue. Thus
neither implantation nor decidua formation are essential for at least the initial increase in
steady state message levels for the MR and the ASGR.
The rise and fall in message levels for the MR and the ASGR most closely
parallels the rise and fall of progesterone that is seen in the pregnant and pseudopregnant
mouse. We examined the livers of female mice given progesterone for 6 days and found
that the MR, ASGR-1, and ASGR-2 message was increased at least 3-fold (Fig.5). Our
results indicate that progesterone modulates the steady state levels of message for the MR
and the ASGR during pregnancy. Increasing the expression of these highly abundant
endocytic receptors has the potential to have an impact on the clearance of a large
number of different glycosylated hormones and other glycoproteins during pregnancy.
MR-/-ASGR-/- mice do not proceed through parturition normally. The rise
and fall in MR and ASGR message and activity levels in the liver over the course of
pregnancy suggested they play a role in some aspect of pregnancy. Even though the
estrus cycle is longer in ASGR-/- and MR-/-ASGR-/- mice than in Wt or MR-/- mice, all
three receptor genotypes are fertile. However, pregnant MR-/-ASGR-/- mice, unlike
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pregnant Wt, MR-/-, and ASGR-/- mice, do not initiate parturition by day 19.5. Instead,
the pregnancy continues for 2-4 additional days when the pregnant mother and the fetuses
die while attempting to deliver larger than normal pups.

We compared weights for

fetuses in Wt, MR-/-, ASGR-/-, and MR-/-ASGR-/- mice on day 18.5 (Fig.6). The
weights for the three genotypes do not differ significantly from those of Wt mice at day
18.5. Fetuses taken from pregnant MR-/-ASGR-/- mice on day 21 or 22 weigh 1.7 g as
compared to 1.3 g for 18.5 day fetuses indicating that the fetuses continue to develop
after day 19.5 and are not dying in utero.
The initiation of parturition at the appropriate time is a complex process requiring
multiple precisely controlled events to occur [92]. Levels of PGF2α and estrogen
increase while levels of progesterone decrease. The inability of MR-/-ASGR-/- mice to
initiate parturition by day 19.5 is similar to the phenotype observed in mice that have had
genes ablated that regulate the levels of PGF2α and progesterone [93-97]. RU486 is a
progesterone receptor antagonist that can induce parturition in mice that are not able to
reduce their progesterone levels by day 19 [98]. Administration of RU486 to pregnant
MR-/-ASGR-/- mice the evening of day 18 or 19 induces parturition by the next morning
with the delivery of live pups. The ability of RU486 to induce parturition in MR-/ASGR-/- mice suggests that some aspect of the pathway that regulates progesterone
production late in pregnancy is not functioning in a normal fashion in MR-/-ASGR-/mice.
Late in pregnancy levels of the prostaglandin PGF2α rise. The PGF2α down
regulates the production of activated Stat5 via the prolactin receptor [99]. The reduced
levels of activated Stat5 in combination with PGF2α allow for increased transcription of
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20α-hydroxysteroid dehyrogenase (20αHSD) [100, 101]. 20αHSD in turn converts
progesterone into an inactive metabolite thus reducing the levels of circulating
progesterone and initiating parturition. In addition, estrogen levels rise as progesterone
levels fall. PGF2α reaches the same level in MR-/-ASGR-/- and Wt mice (Fig.7A) and
message levels are similar for 20αHSD (Fig.7B) at day 18.5. Plasma estrogen and
progesterone levels were also compared for Wt, MR-/-, ASGR-/-, and MR-/-ASGR-/- on
day 18.5 (Fig.7C and D). Estrogen levels are similar in Wt and ASGR-/- mice whereas
they are decreased in both MR-/- and MR-/-ASGR-/-. Levels of progesterone are similar
or less than Wt in ASGR-/- and MR-/-ASGR-/- mice but increased in MR-/- mice. Thus,
in the absence of the MR it appears pregnant mice have difficulty increasing their
production of estrogen prior to parturition whereas only MR-/- mice are not able to
reduce their progesterone levels to those of Wt mice.

80

Discussion
The steroid hormones progesterone, estrogen, testosterone, and their derivatives
have an impact on a wide range of gender specific processes that require precise
regulation of their concentrations. Regulation of steroid hormone production is
accomplished by a complex feedback system referred to as the hypothalamic-pituitarygonadal (HPG) axis[84]. LH, synthesized by gonadotrophs in the anterior pituitary, is
stored in dense core granules and released upon stimulation by gonadotropin releasing
hormone (GnRH) produced by the hypothalamus. LH activates the LH receptor in the
gonad resulting in increased production of testosterone in males and progesterone and
estrogen in females. Testosterone and estrogen in turn reduce GnRH production by the
hypothalamus.
LH is remarkable because it bears N-linked oligosaccharides that terminate with
the unique sequence SO4-4-GalNAcβ1,4GlcNAc[7-10, 84]. LH bearing terminal
GalNAc-4-SO4 is rapidly removed from the blood by the highly abundant MR expressed
at the surface of hepatic endothelial cells and Kupffer cells[40]. Mice that have had the
sulfotransferase that mediates sulfate addition to the GalNAc on LH ablated, GalNAc-4ST1, produce a form of LH bearing N-linked oligosaccharides that terminated with
Siaα2,6GalNAc rather than GalNAc-4-SO4 [63]. LH bearing Siaα2,6GalNAc is
removed from the blood by another receptor located in parenchymal cells of the liver, the
ASGR. LH bearing Siaα2,6GalNAc is removed from the blood at a slower rate than LH
bearing than GalNAc-4-SO4. As a result the half life of LH in the blood increases from
7.4 m in Wt mice to 10.1 m in GalNAc-4-ST1-/- mice. This results in increased levels of
LH and increased testosterone in male mice and increased estrogen in female mice.
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Sexual development is precocious in both sexes and the mice are fertile. The changes
observed in the GalNAc-4-ST1-/- mice indicate that the carbohydrate structures on LH
play a role in determining the amount of steroid hormone that is ultimately produced in
both sexes.
We have examined the impact of ablating the MR and/or the ASGR in male mice.
The half-life of endogenous LH increases from 8.4 m to 15.6 m in MR-/- mice indicating
that endogenous LH is cleared by the MR and that endogenous LH is modified with
terminal GalNAc-4-SO4. The half life of endogenous LH bearing GalNAc-4-SO4 is
considerably longer in MR-/- mice than was seen for LH bearing Siaα2,6GalNAc in
GalNAc-4-ST1-/- mice. The half life of LH is also prolonged in MR-/-ASGR-/- mice but
not in ASGR-/- indicating that the ASGR does not contribute significantly to the
clearance of endogenous LH. Remarkably LH and testosterone levels are increased in
MR-/-, ASGR-/-, and MR-/-ASGR-/- mice. While the elevated levels of LH in MR-/can be attributed to the increased half life, the increase in LH levels in ASGR-/- mice is
likely to reflect a change in the clearance rate for a glycoprotein recognized by the
ASGR. Take together, the changes seen in males in MR-/-, ASGR-/-, and MR-/-ASGR-/mice indicate that the regulation of LH and steroid hormone levels may be more complex
than anticipated and involve both of the highly abundant carbohydrate-specific receptor
systems.
The changes we observe in female MR-/-, ASGR-/-, and MR-/-ASGR-/- mice
also indicate that both the MR and the ASGR are involved in regulating steroid hormone
levels in vivo. The low levels of LH and estrogen seen in female mice make it difficult
to obtain accurate measurements for comparison among the receptor genotypes. This
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difficulty is compounded by the cyclic variation associated with the different stages of
the estrus cycle. The uterus is sensitive to estrogen levels and can be used as an indicator
of relative estrogen levels in vivo. In contrast to GalNAc-4-ST1-/- mice that have uteri
with a mean weight that is 2.3 fold greater than in Wt mice [63], the weight of the uterus
is not increased in MR-/- or ASGR-/- mice and is reduced to half the weight of Wt mice
in MR-/-ASGR-/- mice. Thus, in contrast to male MR-/-, ASGR-/- and MR-/-ASGR-/mice that have elevated levels of LH and testosterone the female MR-/-, ASGR-/- and
MR-/-ASGR-/- mice have normal or low levels of estrogen. The mice are nonetheless
fertile and able to proceed normally with pregnancy until the time of parturition.
Expression of the MR and both subunits of the ASGR is highly regulated during
pregnancy. The steady state levels of message for both receptors are increased 3-5 fold
by the time of implantation on day 4 and increase to a maximum on day 12.5 after which
both begin to decline. The increase in message does not require implantation or decidua
formation and largely parallels the levels of progesterone. Progesterone increases MR
and ASGR message expression in non-pregnant mice and RU486 inhibits the increase in
message level in pseudopregnant mice. Thus, progesterone appears to be a major
regulator of MR and ASGR expression during pregnancy. Even though MR-/-ASGR-/mice proceed through pregnancy without obvious difficulty they do not enter parturition
and deliver the morning of day 19. The initiation of parturition is a complex process. In
the mouse PGF2α begins several days before parturition while progesterone begins to
fall. The rapid fall in progesterone is a result of the action of 20αhydroxysteroid
dehyrdrogenase (20αHSD) that converts progesterone into an inactive metabolite.
Transcription of 20αHSD is suppressed in the ovary during pregnancy by the action of
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Stat5a. The levels of activated Stat5 are maintained by activation of the PRL receptor by
PRL and PLPs produced in the placenta and decidua of the mouse [102, 103]. Increased
PGF2α down regulates the PRL receptor and reduces the levels of activated Stat5
resulting in increased transcription of 20αHSD. This series of events results in the fall in
progesterone that is required to initiate parturition.
The inability of MR-/-ASGR-/- mice to initiate parturition and the ability of
RU486 to overcome this block suggests that these mice are not able to regulate
progesterone levels appropriately near the end of pregnancy. However, we have
examined PGF2α, progesterone, and 20αHSD message levels in MR-/-ASGR-/- mice
and found them to be similar to Wt mice. We have examined progesterone and estrogen
levels in MR-/-, ASGR-/-, and MR-/-ASGR-/- mice at day 18.5 and determined
progesterone is high in MR-/- mice and estrogen is low is MR-/- and MR-/-ASGR-/mice. These differences indicate that the ablating of either or both of these receptors
compromises that ability to control steroid hormone levels late in pregnancy.
We previously determined that the N-linked oligosaccharides on a number of the
PLPs produced by the placenta in rodents are modified with terminal Siaα2,6GalNAc
[12] and may represent the first examples of endogenous ligands for the ASGR since they
do not require further modification to be recognized; i.e. removal of the terminal Sia. It
is likely that one or more of the PLPs produced during pregnancy are elevated in the
blood of pregnant mice and may account for inappropriate activation of a prolactin
receptor. Likewise the inability to clear LH and other glycoproteins bearing terminal
GalNAc-4-SO4 may prevent the episodic rise and fall in circulating LH levels that is
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thought to be required for maximal activation of the LH receptor. Thus, estrogen my not
reach levels that are required for critical functions at the time of parturition.
The initiation of parturition requires multiple precisely timed events to occur.
Further studies will be required to determine which combination of events is
compromised to the extent of preventing parturition in MR-/-ASGR-/- mice. However,
the current studies demonstrate that the MR and the ASGR both play roles in regulating
steroid hormone production by determining the half lives and circulating levels of key
glycoproteins. The changes in expression of the MR and the ASGR that occur during
pregnancy and appear to reflect the action of progesterone may ultimately explain a
number of the changes associated with pregnancy as well as gender specific differences.
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Abbreviations
LH, luteinizing hormone; PLP, prolactin-like protein; PRL, prolactin; Sia, sialic acid;
GalNAc, N-acetylgalactosamine; Wt, wild type; MR, mannose/GalNAc-4-SO4 receptor;
ASGR, asialoglycoprotein receptor; ST1, GalNAc-4-sulfotransferase 1; PGF2α,
Prostaglandin F2 alpha; 20αHSD, 20 alpha hydroxysteroid dehydrogenase; HPG,
hypothalamic-pituitary-gonadal; GnRH, gonadotropin releasing hormone.
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Tables.
Table 1. qPCR primers for ASGR1, ASGR2, and MR reactions.
Primer

Sequence

ASGR1F

GCCTTGGACTGAAGCTGACAA

ASGR1R

GGTCAGTTAGGCCAATCCAA

ASGR2F

GGGTGGATGGAACTGATTA

ASGR2R

GGCAGAAGTTGTCATTCCAA

MRF

GGGTCAGGCTTCTCTGGAA

MRR

GGTTCAACACGGTATGACAGA
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Figures.
Figure 1. The ovulatory cycle of Wt, MR-/-, ASGR-/-, and MR-/-ASGR-/-. Vaginal
smears were collected daily for 20 days in 10 mice of each genotype to observe the
ovulatory cycle of Wt, MR-/-, ASGR-/-, and MR-/-ASGR-/- mice. The length of the
estrus cycle was determined based on the average number of cycles each mouse
underwent. The length of the estrus cycle is 5.3 days in Wt mice. It is 1.6 days longer in
ASGR-/- mice, taking 6.9 days (p=0.0018) and 1.2 days longer, 6.5 days (p=0.0025) in
MR-/-ASGR-/- mice. MR-/- mice had a normal length cycle.
Figure 2. The uterus is small in MR-/-ASGR-/- mice. Uteri were collected randomly
from Wt, MR-/-, ASGR-/-, and MR-/-ASGR-/- mice. MR-/-AR-/- have small, thin uteri
as compared to Wt, averaging 0.04401 g compared to 0.07905 g (p=0.0153).
Figure 3. MR and ASGR message levels change throughout pregnancy. Livers were
collected from pregnant Wt, MR-/-, AR-/-, and MR-/-AR-/- mice at days 0, 3, 6, 9, 12,
15, 18 days of pregnancy and postnatal day 2. Livers were processed and the message
levels for (A) HL1 and (B) HL2 of the AR and the (C) MR were determined using qPCR.
We found the message for HL1 and HL2 of the AR and the MR elevate the first 12 days
of pregnancy and then slowly decline until they reach nearly baseline at postnatal day 2
of pregnancy.
Figure 4. MR and ASGR message levels elevate during pseudopregnancy. Wt
females were mated with Wt males and day 1 of pregnancy was documented after seeing
a vaginal plug. The females were separated into two groups; group one females were
unmanipulated and group two females had oil injected into their uterine horn at day 4 of
pregnancy. At day 9 of pregnancy, females were sacrificed and their livers were
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collected for analysis. Message levels for (A) HL1 and (B) HL2 of the ASGR and (C)
the MR were determined. Both groups of females have up to 6-fold elevated MR and AR
expression at day 9 (p<0.005).
Figure 5. Progesterone injections increase MR and ASGR message levels.
Progesterone, 100 μg, was injected into Wt female mice for 6 days. After 6 days, the
animals were sacrificed and the MR and ASGR message levels were determined by
qPCR. The message of (A) ASGR HL1 was elevated 3 fold (p=0.0053), (B) ASGR HL2
was elevated 4 fold (p=0.0037), and (C) MR was elevated 7 fold (p=0.0028).
Figure 6. Fetuses continue to grow after failed parturition in MR-/-AR-/- mice.
Females that did not induce parturition at day 19 were sacrificed at day 21-22 and the
weight of the fetuses was determined. MR-/-ASGR-/- fetuses weigh 1.7g at day 21-22 as
compared to 1.3 g at day 18.5 (p<0.0001).
Figure 7. PGF2α, 20αHSD, estrogen and progesterone levels during pregnancy in
MR-/-ASGR-/- mice. Circulating plasma PGF2α, 20αHSD, estrogen and progesterone
levels were determined in Wt, MR-/-, AR-/-, and MR-/-AR-/- females. We found all
animals have normal PGR2α and 20αHSD levels at day 18.5, immediately before
parturition is initiated. AR-/- female mice have normal estrogen and progesterone levels
at day 18.5 of pregnancy. MR-/- females have elevated progesterone and decreased
estrogen at day 18.5, although these values are not significant. MR-/-AR-/- mice have
normal progesterone levels and decreased estrogen levels at day 18.5 of pregnancy
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Chapter 6
General Discussion
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In this thesis, I set out to determine how the asialoglycoprotein receptor (ASGR)
and mannose/GalNAc-4-SO4 receptor (MR) regulate circulating plasma protein
concentrations. In the first experiment, we found a number of proteins bearing
Siaα2,6Gal are elevated in mice genetically ablated for the ASGR. Several of the
proteins identified are highly abundant proteins in the plasma, including haptoglobin and
SAP. We suggest the ASGR plays a regulatory role in maintaining circulating plasma
protein levels of proteins bearing Siaα2,6Gal in unperturbed animals. The ASGR and
MR bind and clear proteins bearing Siaα2,6Gal/GalNAc and GalNAc-4-SO4,
respectively. In chapters 3-5, we show the ASGR and MR regulate circulating plasma
proteins levels involved in regulating the acute phase response (APR), hypothalamicpituitary-gonadal (HPG) axis, and pregnancy and parturition. We found that acute phase
proteins (APPs) bearing Siaα2,6Gal elevated in ASGR-/- mice further elevate in ASGR/- plasma, but the fold change is not as dramatic as in Wt plasma, suggesting the ASGR
plays a major role in elevating these proteins in the APR. Proteins bearing
Siaα2,6Gal/GalNAc or GalNAc-4-SO4, including luteinizing hormone (LH) are regulated
by the ASGR and MR for a properly functioning HPG axis. Finally, during pregnancy
and parturition, the ASGR and MR elevate and regulate plasma protein concentrations of
proteins involved in pregnancy and parturition. MR-/-ASGR-/- mice are unable to
induce parturition and this leads to the death of the mother and fetus. We suggest the
ASGR and MR play a regulatory role in maintaining plasma protein concentrations of
proteins bearing Siaα2,6Gal/GalNAc and GalNAc-4-SO4 in unperturbed animals and
assists in elevating the plasma protein levels following perturbations during the APR and
pregnancy.
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The ASGR clears glycoproteins bearing Siaα2,6Gal.
The asialolglycoprotein receptor (ASGR) is a highly abundant protein with up to
500,000 receptors per hepatocyte [23]. For nearly 30 years, the function of this receptor
was believed to be clearance of glycoproteins bearing Gal/GalNAc terminating
oligosaccharides. However, proteins bearing this structure were never identified. The
ASGR has been studied extensively with little success elucidating the function until
recently. Here, we identify endogenous ligands for the ASGR and begin to understand its
role in vivo.
Proteins bearing terminal Gal/GalNAc would be cleared so rapidly from the
plasma, they would never be found circulating. To identify proteins bearing terminal
Gal/GalNAc, two genetic knockout mouse models were generated, one for each subunit
of the ASGR , and elevated proteins were sought after [31, 32]. However, no proteins
bearing terminal Gal/GalNAc were identified as elevated in the plasma. This finding was
interesting since it had been presumed for years that the ASGR clears proteins bearing
terminal Gal/GalNAc, and proteins bearing terminal Gal should be elevated in ASGR-/plasma. There are two possibilities for why these proteins were not found: they are
cleared by another mechanism or proteins bearing terminal Gal rarely exist in the plasma.
While studying ligands of a different receptor clearance system, our lab
encountered proteins bearing the unique structure Siaα2,6GalNAc in the plasma.
Surprising, we found proteins bearing Siaα2,6GalNAc bind to the ASGR. Further
studies determined neoglycoconjugates bearing this structure are cleared rapidly and
using the genetic mouse models previously generated, we determined clearance was by
the ASGR [6, 33]. Few proteins have this oligosaccharide, and the proteins identified,
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prolactin-like proteins [12], are only present in the placenta during pregnancy, making
them unlikely candidates to fulfill the main function of such an abundant receptor.
However, more common structures bearing Sia, Siaα2,6Gal and Siaα2,3Gal exist
plentifully in the plasma. Based on our observation that the ASGR can bind proteins
unmodified by a neuraminidase, we proposed the ASGR binds and clears proteins
bearing on of these more common structures, and the function of the ASGR is to regulate
circulating plasma protein levels of proteins bearing Sia.
To test our hypothesis that the ASGR binds and clears proteins bearing Sia, we
expressed the CRD of ASGR HL-1 and observed binding. We found that
neoglycoconjugates bearing Siaα2,6Gal bind ASGR HL-1 with a lower affinity than
terminal Gal but a higher affinity than Siaα2,3Gal, suggesting proteins bearing
Siaα2,6Gal bind specifically to ASGR HL-1. Clearance studies comparing Gal and
Siaα2,6Gal were conducted [6]; however, proteins bearing Siaα2,6Gal are plentiful in the
plasma and we would need to inject enough exogenous ligand to outcompete the
endogenous ligands. Addtionally, Siaα2,6Gal has a long half-life, making these
experiments difficult. Using traditional clearance studies, it was impossible to verify the
ASGR clears proteins bearing Siaα2,6Gal [34].
Recently, Grewal et al [37]studied several elevated proteins in ASGR-/- mice.
Using knockout mice ablated for HL-1 and HL-2, they found elevations in
vonWillebrand factor (vWF) in HL-1-/- mice, but not HL-2-/- mice. This finding is
interesting because we found in HL-2-/- mice, there is no binding activity of
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asialoglycoproteins. Nonetheless, they found the HL-1-/- mice had reduced bleeding
times and platelet elimination following desialylation by Streptococcus pneumoniae.
We used alternative techniques including two dimensional difference gel
electrophoresis and lectin blotting to identify endogenous ligands for the ASGR, by
identifying elevated proteins in ASGR-/- mice. In chapter 2 of this thesis, we identified
multiple proteins that are elevated in ASGR(-/-) plasma, and determined the elevated
proteins bear Siaα2,6Gal. The proteins identified are abundant proteins, including
haptoglobin and SAP. Specific isoforms are more significantly elevated than others,
likely those isoforms bearing more Siaα2,6Gal, but the overall concentration of these
proteins is elevated in the plasma. We have begun using a new method involving mass
spectrometry to verify proteins that are elevated. The new technique quantifies the
frequency of specific peptides seen in the plasma by mass spectrometry, and the proteins
that are found most frequently are identified. Using this new technique, we identified a
number of proteins elevated in ASGR(-/-) plasma, including haptoglobin. We conclude
proteins bearing Siaα2,6Gal are the main ligands for the ASGR.
We have identified endogenous ligands for the ASGR, and determined the ASGR
regulates plasma protein concentrations. We must now determine the purpose of rapid
clearance by the ASGR. We propose the ASGR in involved in plasma protein turnover
and that each protein has a set concentration and to maintain their set point, proteins are
synthesized and cleared by their functional receptor and by the maintenance receptor, in
this case the ASGR.
To determine the importance of clearance by the ASGR in plasma glycoprotein
turnover, we must look at synthesis and degradation rates in Wt and ASGR-/- mice.
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Using stable isotopic labeling and the mass spectrometry technique described previously,
we can quantify turnover rates of proteins in mice. Briefly, stable isotope is administered
to the animal, the stable isotope be incorporated into proteins for a specific amount of
time and the ratio of labeled to unlabeled protein allows us to determine the fractional
synthesis rate and fractional clearance rate. By determining fractional synthesis clearance
rates, we can determine the significance of clearance compared to synthesis by the ASGR
increases plasma protein concentrations.
The proteins that were identified as elevated in the plasma are abundant proteins,
and could individually saturate the receptor. This suggests there must be a hierarchy of
clearance of these proteins. We propose the ASGR regulates these proteins based on their
current concentration and their affinity.

Experiments determining how proteins

compete for the ASGR are necessary to completely understand the function of the ASGR.
Experiments using a method such as the Biacore can be conducted to determine the how
proteins bind to the ASGR based on their concentration and affinity. The ASGR can be
immobilized on a Biacore Chip and binding of proteins with different concentrations and
affinities can be determined to elucidate the competition of ligands for the ASGR.
The MR is a second highly abundant endocytic receptor found in the liver [40].
The MR clears glycoprotein hormones bearing GalNAc-4-SO4; however, it is unknown
whether this is the main function of the MR. The MR may also play a functional role in
regulating the concentration of proteins bearing GalNAc-4-SO4 and mannose. It is
necessary to determine if the MR has a function similar to that of the ASGR in
unperturbed animals for determining the overall function of these two highly abundant
receptors.
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The ASGR regulates circulating plasma protein levels during the APR
Many of the proteins found elevated in ASGR-/- mice are acute phase proteins
(APPs) and therefore, the ASGR may play a major role in the acute phase response. The
APR is a response to infection, tissue injury or trauma in which a number of APPs
dramatically change in response to inflammation [64]. There are two types of APPs,
negative APPs and positive APPs [75]. Negative APPs include normal blood proteins
such as albumin and transferrin. Positive acute phase proteins include proteins we
identified in ASGR-/- plasma, including haptoglobin and SAP. At the site of the
inflammation, a number of proinflammaotry cytokines are release, and these
inflammatory cytokines including IL-1, IL-6, and TNF-α stimulate synthesis of APPs in
the liver. Synthesis of APPs occurs within hours of the stimulus [70]. The protein
changes seen during an APR are drastic and it is difficult to assume these changes are
done entirely by increased synthesis. Synthesis may play a major role in increasing the
concentration of APPs, but we propose decreased clearance by the ASGR also plays a
major role.
It has previously been shown Siaα2,6Gal terminating proteins play a critical role
in the APR. Proteins bearing small amounts of terminal Gal may exist in the plasma, but
the amount of Gal or the orientation of the oligosaccharide is not sufficient for clearance
by the ASGR. In unstressed animals, some Gal remains uncapped. During the APR,
nearly 100% of the Gal residues are capped [73]. Additionally, the expression of
α2,6sialyltransferase that adds Sia to Gal, ST6GalI elevates during the APR [72]. This
suggests the structure Siaα2,6Gal plays a major role in the APR, perhaps by blocking
clearance of proteins bearing Siaα2,6Gal.
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Studies byTreichel et al [35]have shown the expression levels of the ASGR
decrease in HepG2 cells during the APR. The cytokine IL-2 shuts down the ASGR
within hours of exposure. Within 4 hours of exposure to IL-2, only 50% of the binding
activity remains due to inactivation of the receptor by phosphorylation. Additionally, the
message levels of the ASGR are greatly reduced within hours. We propose that down
regulation of the ASGR plays a major role of elevating APPs bearing Siaα2,6Gal. If this
is the case, in ASGR-/- plasma, we should not see as dramatic a fold change of the APPs
because the only mechanism of elevation of proteins in these animals will be synthesis.
Previous experiments suggest that the oligosaccharide structures present on
proteins and down regulation of the ASGR are important for an APR. In Chapter 3, we
utilized ASGR-/- mice to further our understanding of the function of the ASGR during
the APR. Based on Chapter 2, we know APPs are significantly elevated in ASGR-/mice. We used ASGR-/- mice to determine the significance of protein clearance by the
ASGR during the APR. We found that many proteins that are elevated in unperturbed
animals further increase during the APR. Following the induction of the APR, 24 hrs
later, specific isoforms of proteins including haptoglobin and SAP are significantly
elevated. However, the initial levels of these proteins are higher, and the fold change of
these proteins is not as significant as the fold change seen in Wt plasma. This suggests
that during the APR, increased synthesis and decreased clearance by the ASGR work
together to elevate APPs. We propose the ASGR regulates the concentration of proteins
during the APR. In the absence of the ASGR, this mechanism for increasing plasma
protein concentrations is unavailable, making their fold changes less.
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In order to better understand the function of the ASGR in the APR, it must first be
determined how the ASGR protein expression changes throughout the APR in Wt mice.
The ASGR may be down-regulated to increase plasma protein levels during the APR,
then up-regulated to return plasma protein levels to normal levels after the inflammation
has been resolved. Determination of protein expression changes throughout the APR will
aid in determining its precise function in altering plasma protein levels. Traditional
binding studies can be used to determine the role of the ASGR throughout the APR.
Once it has been better established how the ASGR regulates plasma proteins
levels throughout the APR, it is important to understand how synthesis and clearance by
the ASGR work together to elevate plasma protein levels, and how much each
mechanism is involved in changes the levels. Using stable isotopic labeling as previously
described, we can assess the significance of decreased clearance compared to elevated
synthesis in elevating APP concentrations.
The MR may also play a major role in the regulation of glycoproteins bearing
GalNAc-4-SO4 or mannose during the APR. Lee et al [52]identified four APPs elevated
in unperturbed MR(-/-) mice the COOH-terminal propeptide domains of the pro-alpha 1
and 2 chains of type 1 procollagen and the pro-alpha 1 chain of type III procollagen which
are elevated during wound healing, and fetuin-B. Additional proteins may be elevated in
MR during the APR, they were just undetectable using previous techniques.
Determination of proteins elevated in MR-/- plasma compared to Wt plasma in
unperturbed animals will give us an idea of whether this receptor is involved in the
clearance of APPs. Once we have identified elevated proteins in unperturbed animals,
we will identify proteins bearing GalNAc-4-SO4 and mannose elevated in animals
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undergoing an APR. We will also determine whether the MR follows a similar pattern of
inactivation and down regulation within hours of the APR.
The HPG axis is regulated by the ASGR and MR
The hypothalamic-pituitary-gonadal (HPG) axis regulates circulating levels of
glycoprotein hormones produced in the pituitary and steroid hormones produced in the
gonads. A key regulator of the HPG axis is LH, a glycoprotein hormone bearing
GalNAc-4-SO4 [8-10]. LH binds to the LHR on the gonads causing production of steroid
hormones. The steroid hormones signal back to the hypothalamus and pituitary signaling
for more or less production and release of LH. This closed feedback loop is essential for
regulation of the HPG axis and alterations in regulation, specifically high levels of LH
often leave animals and humans infertile due to desensitization of the LHR.
Our lab has determined the main oligosaccharide structure on LH is GalNAc-4SO4, and LH is rapidly cleared by the MR [40]. While we have elucidated LH is cleared
by the MR, the impact on circulatory half-life in vivo remains unknown. Rapid clearance
of LH by the MR has been proposed to be essential for episodic stimulation of the LHR.
Changing the half-life may cause chronic stimulation of the LHR leading to infertility.
Previously, Risma et al [104] overexpressed bLH-CTP in mice to produce a
model of elevated LH. They found that elevated LH levels leads to chronic anovulation
and infertility in females. The ovaries were enlarged with multiple cysts and packed with
corpus luteum. Males expressing bLH-CLP were fertile. Additionally, elevated LH
levels cause precocious puberty. Chronically elevated LH clearly has an impact on
reproduction and we examined the significance of having elevated endogenous LH. By
altering the circulatory half life, we may cause changes in the circulatory half life and
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altered fertility. To address this issue we have examined the affects of changing the
oligosaccharide structure on circulatory half life.
Recently, our lab generated a genetic mouse model lacking the transferase that
adds sulfate to GalNAc, GalNAc-4-sulfotransferase (G4ST). We expected LH to bear
terminal GalNAc and have a more rapid clearance rate. Surprisingly, we found in the
absence of the G4ST, the oligosaccharide is modified with Sia and the final structure is
Siaα2,6GalNAc, a structure presumably cleared by the ASGR. We found the circulatory
half-life of LH in these animals is longer causing elevated LH; however, they are fertile,
suggesting the LHR is still episodically stimulated. There have physiologic changes
associated with elevate LH; males have elevated testosterone and females have elevated
estrogen, and all mice undergo precocious puberty. Additionally, females have nearly
50% more litters compared to Wt females [63]. Understanding how the MR and ASGR
regulate circulating LH levels is critical for understanding the precise role of LH in
regulating the HPG axis.
In Chapter 4, we studied the role of the ASGR and MR in regulating LH levels.
We found LH levels to be elevated in ASGR and MR plasma; however, the clearance rate
of LH was only altered when we knocked out the MR. This suggests the main
oligosaccharide structures found on LH are GalNAc-4-SO4 and there is little, if any,
Siaα2,6GalNac. Circulating LH levels are elevated in ASGR(-/-) mice, through a
mechanism other than clearance. One likely possibility that there is a protein(s) bearing
Siaα2,6Gal/GalNAc in the plasma that regulates production or release of LH in the
pituitary, and elevation of this protein is causing elevated LH in the plasma.
Interestingly, all mice are fertile. LH signals to the gonads for steroid hormone
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production, including testosterone and estrogen, and we have shown in male mice,
elevated LH causes elevated testosterone and enlarged seminal vesicles. In female mice,
the estrus cycle is prolonged in AR-/- and MR-/-AR-/-.
Elevated LH caused by ablation of either the MR or the ASGR does not have any
extraordinary affect on the gonads. The testes have similar gene expression of LHR,
StAR, 20αHSD, inhibin and activin. Ablation of both receptors, however, has dramatic
affects on the gene expression. The expression of all these genes is elevated, suggesting
the lack of clearance of LH in combination with the lack of clearance by an unidentified
protein cleared by the ASGR results in the increase expression of these genes.
Changing the circulatory half life of LH in vivo clearly affects regulation of the
HPG axis. By modifying the oligosaccharides structures, we have significantly altered
the half life of LH and generated mice that are more fertile. By removing a main
mechanism of clearance, the MR , we have significantly altered half life, but these
animals are not more fertile. The differences seen are likely due to the stimulation of the
LHR. By altering the oligosaccharide structure, the half life is longer, but there is still
specific clearance by the ASGR. By removing the MR, clearance may not be specific,
but rather through the kidney.
In order to better understand the significance of circulatory half life on LH, we
must determine the affects of increased half life on reproduction. Mice with elevated LH,
by either overexpressing bLH-CTP or changing the oligosaccharide structure, undergo
precocious puberty. Mice lacking the MR, ASGR, or both have elevated LH and should
also undergo precocious puberty. Additionally, mice with LH bearing Siaα2,6GalNAc
are more fertile. We have not observed an obvious increase in fertility in MR-/- or
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ASGR-/- mice, but the frequency of litters is important in understanding the importance
of episodic stimulation in these mice and should be documented.
The clearance rate of LH is not altered in ASGR-/- mice, but LH is elevated.
There must be a protein bearing Siaα2,6Gal/GalNAc elevated in the plasma of these
animals causing elevated LH. The protein is likely coming from the testes. When the
testes are intact, there is increased expression of LH in the pituitary. However, once the
testes have been removed through castration, the expression of LH is similar to Wt
expression. We are in the process of using gene chip analysis to identify genes whose
expression is elevated in MR-/-, ASGR-/-, and MR-/-;ASGR-/- testes to identify gene
expression elevations in MR-/-, ASGR-/-, and MR-/-ASGR-/- mice. Identification of
elevated genes will allow us to more completely understand the HPG axis by identifying
additional proteins involved in the regulation of LH.
The ASGR and MR are regulated during pregnancy and parturition
For a successful pregnancy in mice, steroid hormone levels must change
dramatically. Progesterone levels are high throughout pregnancy [105]and estrogen
levels are low. Immediately before parturition, progesterone levels rapidly decline and
estrogen levels increase. Regulation of progesterone levels is done through 20αHSD, an
enzyme that converts progesterone to its inactive metabolites. During pregnancy,
prolactin binds to the prolactin receptor on the ovary causing decreased transcription of
20αHSD [101]. At the time of parturition, PGF2α down regulates the prolactin receptor
and up regulates production of 20αHSD, causing the conversion of progesterone to
inactive metabolites and therefore decreasing the concentration of progesterone in the
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blood [100]. The rapid decline of progesterone is thought to be necessary to induce
parturition.
In Chapter 5 of this thesis, we studied the role of the MR and ASGR in
reproduction of female mice. We found ASGR-/- and MR-/-ASGR-/- mice have slightly
but significantly longer estrus cycles, but all three genotypes are fertile. Interestingly,
mice with both receptors ablated undergo what appears to be a normal pregnancy, but
they do not induce parturition and ultimately die. We studied the mRNA expression
levels of the MR and ASGR throughout pregnancy and found the expression of both
receptors changes significantly throughout pregnancy. Additionally, we found through
pseudopregnancy, the changes in the receptor expression are driven by the mother, and
the presence of deciduas is not necessary.
Our lab is currently conducting several experiments to further understand
pregnancy and parturition. First, we are trying to understand the regulation of the MR
and ASGR during pregnancy. The expression of MR and ASGR rapidly increases within
the first couple days of being pregnant and peaks at day 12.5. Additionally, it has been
previously shown binding of the ASGR increases throughout pregnancy, suggesting there
are changes in plasma proteins that need to be regulated by the ASGR. The cause of this
elevation is unknown. Progesterone elevation and decline follows a similar pattern to
that of the receptors, suggesting progesterone may be the cause of the expression
changes. Experiments are underway to determine whether progesterone is the cause of
the expression changes. Pseudopregnant mice will be injected with RU486, a
progesterone antagonist to determine whether progesterone is driving the expression
changes.
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There is clearly a problem with MR-/-ASGR-/- mice entering parturition. We had
hints that the cause of the problem was progesterone, because injection of RU486 results
in parturition and the mother and fetuses are saved. However, our preliminary studies
suggest progesterone levels in MR-/-ASGR-/- are not different compared to Wt.
Additionally, we have determined PGF2α protein levels and 20αHSD mRNA expression
levels are normal in MR-/-ARGR-/- mice. There have been suggestions that it is not
progesterone alone that induces parturition, but the progesterone:estrogen ratio. We have
shown estrogen levels may be low in MR-/-ASGR-/-, but further studies on these levels
and the progesterone:estrogen ratio are necessary to completely understand the problem
with parturition in these mice.
Finally, delayed clearance of one or more proteins in the MR-/-ASGR-/- plasma
must be accounting for the inability to induce parturition. We previously identified
prolactin-like proteins bearing Siaα2,6GalNAc that are likely regulated by the ASGR.
Additional proteins bearing Siaα2,6GalNAc and GalNAc-4-SO4 may play a critical role
in parturition. Identification of these proteins will be necessary in completely
understanding parturition. Using mass spectrometry, we will compare 18.5 day pregnant
Wt, MR-/-, ASGR-/-, and MR-/-ASGR-/- plasma to identify elevated proteins in the
plasma of MR-/-ASGR-/- plasma.
Conclusions
In this thesis, I have shown clearance of glycoproteins bearing
Siaα2,6Gal/GalNAc and GalNAc-4-SO4 is critical for multiple functions including
inducing the acute phase response and parturition. Genetically altered mice lacking the
ASGR have elevated levels of multiple plasma proteins including haptoglobin, SAP, and
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LH. Haptoglobin and SAP bear the common structure Siaα2,6Gal and their clearance
rate is reduced due to loss of the ASGR. The clearance rate of LH is not altered,
suggesting there is an unidentified protein bearing Siaα2,6Gal/GalNAc involved in
regulating production or release that is regulated by the ASGR.
The MR plays a clear role in determining the circulatory half life of LH in vivo,
and the precise circulatory half life is important. We have shown drastic changes in the
half life results in drastically different phenotypes. Further experiments to elucidate the
role of both the MR and ASGR in reproduction are necessary to further our
understanding of the function of these receptors in reproduction.
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Abbreviations
ASGR, asialoglycoprotein receptor; MR, mannose/GalNAc-4-SO4 receptor; Sia, sialic
acid; Gal, galactose; GalNAc, N-acetylgalactosamine; APR, acute phase response; APP,
acute phase protein; HPG, hypothalamic-pituitary-gonadal; HL, hepatic lectin; CRD,
carbohydrate recognition domain; SAP, serum amyloid P; LH, luteinizing hormone;
G4ST, GalNAc-4-sulfotransferase; LHR, LH receptor; 20αHSD, 20 alpha hydroxysteroid
dehydrogenase; PFG2α, Prostaglandin F2α; StAR, sterogenic acute regulatory protein;
PLP, prolactin-like protein.
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